Craig Mayer, Nick WIlliams, Vojtech Huser
Lister Hill National Center for Biomedical Communications, National Library of Medicine, NIH, Bethesda, MD

See the full regCTG repository at https://github.com/lhncbc/CRI/tree/master/regCTG

To return to the list of conditions and view other reports go to https://lhncbc.github.io/CRI/regCTG/regCTG-condition_report_links.html


Study Counts

Type Study_count
Total_Studies 3629
interventional 3177
Observational 426
Registry 26

Studies over Time by Start Date

```

Interventional Trials

Intervention Type

intervention_type Study_Count
Drug 1679
Biological 272
Drug|Other 183
Biological|Drug 173
Drug|Procedure 99
Biological|Drug|Other 79
Biological|Drug|Procedure|Radiation 66
Biological|Drug|Procedure 61
Drug|Procedure|Radiation 58
Other 57
Drug|placebo 49
Procedure 45
Drug|Radiation 33
Biological|Drug|Other|Procedure|Radiation 27
Drug|Other|Procedure|Radiation 27
Behavioral 26
Biological|Drug|Radiation 22
Biological|Other 20
Drug|Other|Procedure 17
Biological|Drug|Other|Procedure 14
Device 11
Biological|Procedure 10
Combination Product 9
Dietary Supplement 9
Drug|Genetic|Other 9
Device|Drug|Procedure 7
Other|Procedure 7
Drug|Genetic 6
Drug|Other|Radiation 6
Behavioral|Other 5
Biological|Drug|Genetic|Other|Procedure 5
Biological|Device|Drug 4
Dietary Supplement|Drug 4
Dietary Supplement|placebo 4
Drug|Genetic|Other|Procedure 4
Genetic 4
Radiation 4
Biological|Other|Procedure 3
Biological|Procedure|Radiation 3
Device|Drug 3
Biological|Combination Product 2
Biological|Drug|Genetic|Other 2
Biological|Drug|Other|Radiation 2
Biological|Drug|placebo 2
Biological|Genetic|Other 2
Biological|Other|placebo 2
Device|Drug|Other 2
Device|Other 2
Diagnostic Test|Drug|Genetic|Procedure|Radiation 2
Dietary Supplement|Other 2
Drug|placebo|Procedure 2
Genetic|Other 2
Genetic|Procedure 2
Behavioral|Dietary Supplement|Other 1
Behavioral|Dietary Supplement|Other|Procedure 1
Behavioral|Drug 1
Behavioral|Drug|Other|Procedure 1
Behavioral|Other|Procedure 1
Biological|Combination Product|Drug 1
Biological|Device 1
Biological|Device|Drug|Other 1
Biological|Device|Drug|Other|Procedure 1
Biological|Device|Drug|Procedure|Radiation 1
Biological|Device|Drug|Radiation 1
Biological|Dietary Supplement|Drug|placebo 1
Biological|Dietary Supplement|Drug|Procedure 1
Biological|Drug|placebo|Procedure 1
Biological|Genetic|Other|Procedure 1
Biological|placebo 1
Combination Product|Dietary Supplement 1
Device|Drug|Other|Procedure|Radiation 1
Device|Drug|Procedure|Radiation 1
Device|Other|Procedure 1
Diagnostic Test|Drug 1
Dietary Supplement|Drug|Other 1
Drug|Genetic|Other|Procedure|Radiation 1
Drug|Genetic|Procedure|Radiation 1
Drug|Other|placebo|Procedure 1
Other|placebo|Procedure 1
Procedure|Radiation 1

Count of Studies by Intervention (normalized and mapped)

Interventions over Time

Yearly studies for each intervention by start date

Studies by Country

Country Study_Count
United States 1837
China 147
France 88
Germany 83
United States|Canada 64
NA 60
Italy 58
Japan 49
Spain 45
United Kingdom 39
Canada 31
Korea, Republic of 26
United States|Australia|Canada 22
Austria|Germany 12
Israel 11
Denmark 10
Switzerland 10
United States|France 10
United States|Germany 9
Austria 8
Russian Federation 8
United States|Germany|Italy 8
Brazil 7
Mexico 7
Sweden 7
United States|Australia 7
United States|Israel 7
United States|Italy 7
Australia 6
United States|Canada|Puerto Rico 6
Belgium 5
Egypt 5
Hong Kong 5
Netherlands 5
United States|Australia|Canada|Netherlands|Puerto Rico|Switzerland 5
United States|United Kingdom 5
Norway 4
Singapore 4
Turkey 4
United States|Australia|Canada|Netherlands|New Zealand|Puerto Rico|Switzerland 4
United States|Australia|Canada|New Zealand|Puerto Rico 4
United States|Australia|Canada|Puerto Rico 4
Denmark|Finland|Iceland|Norway|Sweden 3
Germany|Austria 3
Germany|Netherlands 3
Germany|Switzerland 3
Iran, Islamic Republic of 3
Malaysia 3
United States|Australia|Canada|New Zealand 3
United States|Australia|Canada|New Zealand|Puerto Rico|Saudi Arabia 3
United States|Australia|Canada|New Zealand|Switzerland 3
United States|Canada|Puerto Rico|Switzerland 3
United States|France|Germany 3
United States|France|Germany|Italy|United Kingdom 3
United States|Korea, Republic of 3
United States|Puerto Rico|South Africa 3
Austria|France|Germany 2
Austria|France|Germany|Italy|Netherlands|United Kingdom 2
Canada|France 2
Finland|Norway|Sweden 2
France|Germany 2
France|United Kingdom 2
India 2
Japan|Korea, Republic of 2
Japan|Korea, Republic of|Taiwan 2
Lebanon 2
Lithuania 2
Poland 2
Spain|United States|Argentina|Australia|Austria|Brazil|Bulgaria|Canada|Croatia|Czechia|Denmark|Egypt|Estonia|France|Germany|Hong Kong|Italy|Mexico|Netherlands|New Zealand|Romania|Russian Federation|Slovakia|Switzerland|Thailand|United Kingdom 2
United States|Australia|Austria|Belgium|France|Germany|Hungary|Italy|New Zealand|Spain|United Kingdom 2
United States|Australia|Belgium|Canada|China|Czechia|Ireland|Israel|Italy|New Zealand|Poland|Russian Federation|Spain|Turkey|Ukraine|United Kingdom 2
United States|Australia|Canada|Ireland|New Zealand|Puerto Rico|Switzerland 2
United States|Australia|Canada|Switzerland 2
United States|Australia|France|Italy|Spain 2
United States|Australia|France|Poland 2
United States|Belgium 2
United States|Canada|France|Germany|Hungary|India|Italy|Poland|Singapore|United Kingdom 2
United States|Canada|France|Germany|Italy|Spain 2
United States|Canada|France|Netherlands 2
United States|Canada|Netherlands|Puerto Rico|Switzerland 2
United States|Denmark|Germany 2
United States|Georgia 2
United States|Germany|Italy|Spain 2
United States|Germany|Netherlands 2
United States|Germany|Spain 2
United States|Poland 2
United States|Puerto Rico 2
United States|Spain 2
United States|Switzerland 2
Algeria|Argentina|Australia|Brazil|Canada|Egypt|India|Israel|Lebanon|Malaysia|Mexico|Oman|Russian Federation|Saudi Arabia|South Africa|Taiwan|Thailand|Tunisia|United Arab Emirates 1
Argentina|Australia|Austria|Belarus|Belgium|Canada|Chile|Croatia|Czechia|Denmark|Finland|France|Germany|Greece|Hungary|Israel|Italy|Malaysia|Mexico|Netherlands|New Zealand|Norway|Poland|Romania|Saudi Arabia|Slovakia|Slovenia|Spain|Sweden|Switzerland|Turkey 1
Argentina|Australia|Brazil|Canada|Chile|Croatia|Czechia|France|Germany|Greece|Italy|Mexico|New Zealand|Poland|Portugal|Russian Federation|Slovakia|Spain|Turkey 1
Argentina|Australia|Brazil|Canada|France|Spain 1
Argentina|Australia|Bulgaria|Hong Kong|Hungary|Mexico|New Zealand|Poland|Russian Federation|Taiwan 1
Argentina|Austria|Belgium|Chile|Czech Republic|Germany|Hungary|Italy 1
Argentina|Belgium|Bosnia and Herzegovina|Brazil|Canada|Egypt|Estonia|Finland|France|Germany|Greece|Ireland|Israel|Italy|Korea, Republic of|Latvia|Lithuania|Mexico|North Macedonia|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|Slovenia|Spain|Sweden|Switzerland|Thailand|Turkey 1
Argentina|Belgium|Canada|Denmark|Finland|France|Italy|Netherlands|Norway|Sweden 1
Argentina|Brazil|China|Colombia|Germany|Guatemala|India|Mexico|Panama|Poland|Russian Federation|Venezuela 1
Argentina|Croatia|Greece|Ireland|Italy|New Zealand|Russian Federation|United Kingdom 1
Argentina|Venezuela 1
Armenia|Belarus|Kyrgyzstan|Russian Federation|Uzbekistan 1
Australia|Austria|Belgium|Czech Republic|Denmark|France|Germany|Israel|Italy|New Zealand|Spain 1
Australia|Austria|Belgium|Czechia|France|Israel|Japan|Spain 1
Australia|Austria|Czechia|Germany|Israel|Italy|Slovakia|Switzerland 1
Australia|Austria|Czechia|Germany|Israel|Italy|Switzerland 1
Australia|Belgium|France|Germany|Italy|Korea, Republic of|Netherlands|Singapore|Spain|Sweden|United Kingdom 1
Australia|Brazil|France|Israel|Italy|Russian Federation|Spain|Switzerland|Turkey 1
Australia|Canada|Estonia|Finland|Germany|Greece|New Zealand|Norway|Sweden 1
Australia|Canada|France|Korea, Republic of|Netherlands 1
Australia|China|New Zealand|Taiwan 1
Australia|France 1
Australia|France|Germany|Hungary|Korea, Republic of|Poland|Singapore|United Kingdom 1
Australia|France|Spain|United Kingdom 1
Australia|United Kingdom 1
Australia|United States|Austria|Belgium|Bulgaria|Canada|Czechia|Denmark|Finland|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Netherlands|Poland|Romania|Russian Federation|Serbia|Spain|Sweden|Taiwan|United Kingdom 1
Australia|United States|Canada|Germany|Israel|Italy|New Zealand|Poland|Romania|Russian Federation|Spain|Sweden|Ukraine 1
Austria|Belgium|Bulgaria|Czechia|France|Germany|Hungary|Ireland|Israel|Italy|Poland|Russian Federation|Singapore|Slovakia|Sweden|Ukraine|United Kingdom 1
Austria|Belgium|Canada|France|Germany|Italy|Japan|Norway|Spain 1
Austria|Belgium|Canada|France|Germany|Italy|Norway 1
Austria|Belgium|Croatia|France|Germany|Italy|Netherlands 1
Austria|Belgium|Croatia|France|Italy|Netherlands 1
Austria|Belgium|France|Germany|Italy|Netherlands|Poland|Romania|Russian Federation|Spain|United Kingdom 1
Austria|Belgium|France|Germany|Italy|Netherlands|Portugal 1
Austria|Belgium|France|Italy 1
Austria|Brazil|United States|Argentina|Australia|Bulgaria|Canada|Croatia|Czechia|Denmark|Egypt|Estonia|France|Germany|Hong Kong|Italy|Mexico|Netherlands|New Zealand|Romania|Russian Federation|Slovakia|Spain|Switzerland|Thailand|United Kingdom 1
Austria|Canada|Finland|Norway|Russian Federation|Sweden 1
Austria|Czechia|Germany|Italy|Poland|United Kingdom 1
Austria|Czechia|Slovakia 1
Austria|Finland|Germany|Russian Federation 1
Austria|Germany|Switzerland 1
Bangladesh 1
Belarus 1
Belarus|Poland 1
Belarus|Russian Federation|Uzbekistan 1
Belgium|Brazil|United States|Australia|Canada|Czechia|Hungary|Korea, Republic of|Mexico|New Zealand|Poland|Puerto Rico|Russian Federation 1
Belgium|Bulgaria|Croatia|France|Germany|Italy|Lithuania|Netherlands|Portugal 1
Belgium|Canada|China|France|Hungary|Italy|Netherlands|Poland|Spain|United Kingdom 1
Belgium|Canada|Croatia|Germany|Portugal|United Kingdom 1
Belgium|Canada|Czech Republic|Finland|France|Germany|United States|Greece|Israel|Slovakia|Switzerland|Turkey|United Kingdom 1
Belgium|Canada|Germany|United Kingdom 1
Belgium|Croatia|Czech Republic|France|Germany|Italy|Netherlands|Portugal|Slovakia|Turkey 1
Belgium|Czechia|France|Germany|Italy 1
Belgium|Czechia|France|Germany|Netherlands|Slovakia 1
Belgium|Denmark|Estonia|Finland|Germany|Iceland|Ireland|Lithuania|Netherlands|Norway|Portugal|Sweden|United Kingdom 1
Belgium|Denmark|Estonia|Finland|Hong Kong|Iceland|Netherlands|Norway|Sweden 1
Belgium|Denmark|France|Germany|Italy|Netherlands|Spain|Sweden|United Kingdom 1
Belgium|Denmark|Netherlands 1
Belgium|France 1
Belgium|France|Germany 1
Belgium|France|Germany|Italy 1
Belgium|France|Germany|Italy|Spain 1
Belgium|France|Portugal 1
Belgium|France|Spain 1
Belgium|Germany 1
Belgium|Germany|Italy|Netherlands|Turkey 1
Belgium|Germany|Netherlands|Switzerland 1
Belgium|Germany|United Kingdom 1
Belgium|Switzerland 1
Bulgaria|Canada|India|Russian Federation|Slovakia|South Africa|Spain 1
Bulgaria|Croatia|Czechia|Estonia|Finland|France|Greece|Hungary|Italy|Lithuania|Norway|Romania|Serbia|Slovakia|Spain|Sweden 1
Bulgaria|Georgia|Poland 1
Canada|France|Germany|Italy|Spain 1
Canada|Germany 1
Canada|Russian Federation|Spain 1
Canada|United States|Australia|Netherlands|New Zealand|Puerto Rico|Switzerland 1
Canada|United States|Australia|New Zealand|Switzerland 1
China|Malaysia|Australia|Taiwan 1
China|Malaysia|Russian Federation|Singapore|Thailand 1
China|Philippines|Taiwan|Thailand|Vietnam 1
Colombia|Venezuela 1
Czech Republic 1
Czechia|Denmark|Finland|France|Germany|Greece|Netherlands|Norway|Portugal|Sweden 1
Czechia|Denmark|France|Germany|Hungary|Israel|Italy|United States|Argentina|Australia|Austria|Brazil|Bulgaria|Canada|Korea, Republic of|Netherlands|Poland|Russian Federation|Saudi Arabia|Slovakia|South Africa|Spain|Sweden|Taiwan|Turkey|United Kingdom 1
Czechia|Germany|Switzerland 1
Czechia|United States|Argentina|Australia|Belgium|Brazil|Bulgaria|Canada|China|Croatia|France|Germany|Hong Kong|Hungary|Israel|Italy|Japan|Korea, Republic of|Poland|Portugal|Romania|Russian Federation|Serbia|Singapore|Spain|Taiwan|Ukraine|United Kingdom 1
Denmark|Estonia|Finland|Lithuania|Norway|Sweden 1
Denmark|Finland|Norway|Sweden 1
Denmark|Germany|Netherlands 1
Denmark|Norway|Sweden 1
Denmark|Sweden 1
Denmark|United Kingdom 1
Finland 1
Finland|Germany|Netherlands|Norway|Sweden 1
France|Austria|Belgium|Czechia|Denmark|Germany|Ireland|Italy|Netherlands|Spain|Sweden|Switzerland|United Kingdom 1
France|Germany|Italy 1
France|Germany|Italy|Netherlands|Spain 1
France|Germany|Italy|United Kingdom 1
France|Germany|Spain 1
France|Switzerland 1
France|United States|Australia|Austria|Belgium|Brazil|Canada|Czechia|Finland|Germany|Ireland|Israel|Italy|Korea, Republic of|Lithuania|Mexico|Poland|Portugal|Russian Federation|Spain|Taiwan|Turkey|United Kingdom 1
Germany|Austria|Belgium|Denmark|Finland|Ireland|Israel|Netherlands|Sweden|Switzerland 1
Germany|Austria|Italy 1
Germany|Netherlands|United Kingdom 1
Germany|United States|Australia|Austria|Belgium|Canada|Denmark|Finland|France|Hong Kong|Italy|Korea, Republic of|Netherlands|New Zealand|Norway|Poland|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
Greece 1
Hong Kong|Japan|Korea, Republic of|Russian Federation|Taiwan|Thailand|Vietnam 1
Hong Kong|Japan|Malaysia|Singapore|Taiwan 1
India|Korea, Republic of|Thailand 1
Indonesia 1
Indonesia|Korea, Republic of|Philippines|Thailand 1
Ireland 1
Ireland|Italy|United Kingdom 1
Italy|Japan|United States|Australia|France|Greece 1
Italy|Saudi Arabia|United Kingdom 1
Italy|United Kingdom 1
Jordan|Lebanon|Saudi Arabia|Tunisia 1
Korea, Republic of|Turkey|Ukraine 1
Netherlands|United Kingdom 1
Peru|United States|Poland|Argentina|Australia|Austria|Belgium|Brazil|Chile|China|Colombia|Czech Republic|Denmark|France|Germany|Greece|Hungary|India|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Russian Federation|Singapore|Spain|Turkey 1
Poland|Spain|Uruguay 1
Poland|United Kingdom 1
Portugal|Spain 1
Saudi Arabia 1
Spain|Finland|France|Portugal|Sweden|Tunisia|Turkey|United Kingdom 1
Spain|United States|Australia 1
Spain|United States|Australia|Austria|Belgium|Canada|Colombia|Czechia|Denmark|France|Germany|Hungary|Ireland|Israel|Italy|Mexico|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|South Africa|Sweden|United Kingdom 1
Spain|United States|Australia|Belgium|Denmark|France|Germany|Hungary|Israel|Italy|Netherlands|New Zealand|Poland|Turkey|United Kingdom 1
Sweden|United States|Belgium|Canada|Czechia|Denmark|France|Germany|Italy|Japan|Korea, Republic of|Poland|Spain|United Kingdom 1
Taiwan 1
Thailand 1
United States|Argentina|Australia|Austria|Belarus|Brazil|Bulgaria|Canada|Finland|France|Greece|Italy|Korea, Republic of|Poland|Russian Federation|Spain|Taiwan|Turkey 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Bulgaria|Czechia|France|Germany|Israel|Italy|Japan|Norway|Poland|Portugal|Spain|Switzerland|Taiwan|Turkey 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|China|Denmark|Estonia|Finland|France|Germany|Hungary|Ireland|Israel|Italy|Korea, Republic of|Norway|Peru|Philippines|Poland|Puerto Rico|Russian Federation|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Czech Republic|Denmark|Finland|France|Germany|Greece|Hungary|Ireland|Israel|Italy|Korea, Republic of|Netherlands|Norway|Peru|Philippines|Poland|Russian Federation|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Czech Republic|Denmark|Finland|France|Germany|Hungary|Ireland|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Norway|Peru|Philippines|Poland|Russian Federation|Singapore|South Africa|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Australia|Austria|Belgium|Brazil|Canada|Denmark|Finland|France|Germany|Israel|Italy|Korea, Republic of|Netherlands|Norway|Peru|Sweden|Switzerland|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Bulgaria|Canada|Croatia|Denmark|Estonia|France|Germany|Italy|Mexico|New Zealand|Poland|Romania|Russian Federation|Spain|Switzerland|United Kingdom 1
United States|Argentina|Australia|Austria|Brazil|Canada|Chile|China|Colombia|Finland|Germany|Hong Kong|Hungary|India|Italy|Korea, Republic of|Mexico|Netherlands|Norway|Peru|Russian Federation|Singapore|South Africa|Spain|Sweden|Taiwan|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Chile|China|Colombia|Finland|France|Hong Kong|Hungary|India|Italy|Japan|Korea, Republic of|Latvia|Netherlands|Peru|Poland|Russian Federation|Singapore|South Africa|Spain|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|China|Czechia|France|Germany|Greece|Hungary|Ireland|Japan|Korea, Republic of|Mexico|New Zealand|Norway|Puerto Rico|Russian Federation|South Africa|Spain|Taiwan|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Denmark|Finland|France|Germany|Israel|Italy|Korea, Republic of|Netherlands|Norway|Peru|Philippines|Singapore|Sweden|Switzerland|Taiwan|Thailand|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|Finland|France|Germany|Hungary|Ireland|Israel|Italy|Korea, Republic of|Norway|Peru|Poland|Russian Federation|South Africa|Spain|Sweden|Switzerland|Thailand|United Kingdom 1
United States|Argentina|Australia|Belgium|Brazil|Canada|France|Germany|Greece|Israel|Japan|Korea, Republic of|Mexico|Poland|Russian Federation|Singapore|Spain|Tunisia|United Kingdom 1
United States|Argentina|Australia|Brazil|Bulgaria|Canada|Czechia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Lebanon|Mexico|Netherlands|Romania|Russian Federation|Saudi Arabia|Serbia|Spain|Switzerland|Turkey|United Kingdom 1
United States|Argentina|Australia|Brazil|Canada 1
United States|Argentina|Australia|Brazil|Canada|France|Germany|India|Italy|Korea, Republic of|Mexico|Netherlands|Romania|Russian Federation|Singapore|South Africa|Spain|United Kingdom 1
United States|Argentina|Australia|Canada|Chile|Czechia|Denmark|France|Germany|Hong Kong|Italy|Korea, Republic of|Poland|Portugal|Russian Federation|Singapore|Spain|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Argentina|Australia|Canada|China|Czechia|Finland|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Netherlands|Poland|Singapore|Spain|Sweden|Taiwan|United Kingdom 1
United States|Argentina|Austria|Belgium|Brazil|Canada|China|Czechia|France|Hungary|Italy|Korea, Republic of|Poland|Spain|Thailand 1
United States|Argentina|Austria|Belgium|Brazil|Canada|Colombia|Czechia|Denmark|Egypt|Finland|France|Germany|Hong Kong|Hungary|Italy|Japan|Korea, Republic of|Malaysia|Mexico|Netherlands|Norway|Poland|Portugal|Russian Federation|Singapore|Slovakia|South Africa|Spain|Sweden|Switzerland|Taiwan|Thailand|Turkey|United Kingdom|Venezuela 1
United States|Argentina|Austria|Belgium|Brazil|Canada|Czechia|Finland|France|Germany|Greece|Hungary|India|Italy|Japan|Korea, Republic of|Mexico|Netherlands|Norway|Poland|Portugal|Russian Federation|South Africa|Spain|Taiwan 1
United States|Argentina|Austria|Belgium|Bulgaria|Colombia|Denmark|France|Germany|Greece|Hungary|Ireland|Italy|Japan|Netherlands|Poland|Spain|Sweden|United Kingdom 1
United States|Argentina|Belgium|Brazil|Canada|Chile|China|Colombia|France|Germany|Hong Kong|Hungary|India|Italy|Japan|Korea, Republic of|Latvia|Lithuania|Mexico|Poland|Russian Federation|Singapore|South Africa|Spain|Taiwan|Thailand|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Belgium|Brazil|Canada|Colombia|Czechia|France|Germany|Greece|Israel|Korea, Republic of|Mexico|Poland|Portugal|Russian Federation|Spain|Sweden|Turkey|Ukraine|United Kingdom 1
United States|Argentina|Belgium|Brazil|Canada|Czechia|Germany|Greece|Hong Kong|Hungary|Ireland|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Poland|Puerto Rico|Russian Federation|Spain|Taiwan|Thailand 1
United States|Argentina|Korea, Republic of|Australia|Austria|Brazil|Czechia|France|Germany|Hungary|Italy|Poland|Romania|Spain|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Bulgaria|Canada|Chile|Colombia|Croatia|Czechia|Denmark|France|Hungary|Israel|Italy|Netherlands|New Zealand|Poland|Portugal|Romania|Russian Federation|Serbia|Slovakia|South Africa|Spain|United Kingdom 1
United States|Australia|Austria|Belgium|Brazil|Canada|China|Czechia|Denmark|France|Germany|Italy|Korea, Republic of|Russian Federation|Spain|Taiwan|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Bulgaria|Canada|Croatia|Czechia|France|Germany|Hong Kong|Hungary|Israel|Italy|Korea, Republic of|New Zealand|Poland|Russian Federation|Singapore|Slovakia|Spain|Sweden|Taiwan|Ukraine|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|China|Czechia|France|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Mexico|Poland|Romania|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|China|Czechia|France|Germany|Israel|Italy|Korea, Republic of|Netherlands|Poland|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|Denmark|France|Germany|Hungary|Italy|Korea, Republic of|Netherlands|New Zealand|Poland|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|France|Germany|Hungary|Italy|Korea, Republic of|New Zealand|Poland|Spain|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Czechia|France|Israel|Italy|New Zealand|Poland|Russian Federation|Spain|Sweden|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Denmark|Finland|France|Germany|Ireland|Israel|Italy|Korea, Republic of|Netherlands|Norway|Peru|Singapore|South Africa|Spain|Sweden|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Denmark|Finland|France|Germany|Israel|Italy|Korea, Republic of|Netherlands|Norway|Philippines|Singapore|Sweden|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Denmark|France|Germany|Italy|Netherlands|New Zealand|Norway|Spain|Sweden|Switzerland|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|France|Germany|Italy|Japan|Norway|Spain 1
United States|Australia|Austria|Belgium|Canada|France|Germany|Netherlands|Norway|Poland|Turkey|United Kingdom 1
United States|Australia|Austria|Belgium|Canada|Germany|Hungary|Netherlands|Norway|Spain|United Kingdom 1
United States|Australia|Austria|Belgium|Czechia|France|Italy|New Zealand|Poland|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Austria|Belgium|France|Germany|Korea, Republic of|Poland|Spain 1
United States|Australia|Austria|Belgium|France|Ireland|Italy|Poland|Spain|United Kingdom 1
United States|Australia|Austria|Brazil|Canada|China|Czechia|France|Germany|Israel|Italy|Spain|Japan|Korea, Republic of|Mexico|Netherlands|Poland|Russian Federation|Taiwan|United Kingdom 1
United States|Australia|Austria|Canada|Chile|Czechia|Denmark|France|Germany|Hong Kong|Italy|Japan|Korea, Republic of|Poland|Portugal|Russian Federation|Spain|Taiwan|United Kingdom 1
United States|Australia|Austria|Canada|Denmark|France|Israel|Italy|Netherlands|Spain|Switzerland|United Kingdom 1
United States|Australia|Austria|Finland|France|Germany|Italy|Netherlands|United Kingdom 1
United States|Australia|Belarus|Brazil|Canada|Israel|Korea, Republic of|Mexico|New Zealand|Poland|Russian Federation|Singapore 1
United States|Australia|Belgium|Brazil|Canada|China|Czechia|France|Germany|Greece|Israel|Italy|Japan|Korea, Republic of|Mexico|Poland|Russian Federation|Spain|Turkey|United Kingdom 1
United States|Australia|Belgium|Canada|Croatia|Czechia|France|Germany|Hong Kong|Hungary|Italy|Korea, Republic of|Netherlands|Poland|Serbia|Singapore|Spain|Taiwan|United Kingdom 1
United States|Australia|Belgium|Canada|Croatia|Czechia|France|Greece|Hungary|Ireland|Italy|Poland|Portugal|Romania|Russian Federation|Spain|Turkey|United Kingdom 1
United States|Australia|Belgium|Canada|Czechia|Denmark|Finland|France|Germany|Hungary|Israel|Italy|Korea, Republic of|Mexico|Netherlands|Norway|Poland|Singapore|Slovakia|South Africa|Spain|Sweden|Taiwan|Thailand|Ukraine|United Kingdom 1
United States|Australia|Belgium|Canada|Denmark|France|Hungary|Italy|Netherlands|New Zealand|Norway|Poland|Romania|Russian Federation|Spain|Sweden|United Kingdom 1
United States|Australia|Belgium|Canada|France|Germany|Ireland|Italy|Norway|Poland|Romania|Spain|United Kingdom 1
United States|Australia|Belgium|Canada|France|Germany|Italy|Japan|Korea, Republic of|Poland|Spain|Taiwan|United Kingdom 1
United States|Australia|Belgium|Canada|Germany|New Zealand|Sweden|Turkey|United Kingdom 1
United States|Australia|Belgium|Canada|Greece|Hungary|Israel|Korea, Republic of|Poland|Russian Federation 1
United States|Australia|Belgium|China|Czechia|France|Germany|Italy|Netherlands|New Zealand|Poland|Spain|Sweden|Turkey|United Kingdom 1
United States|Australia|Belgium|France|Germany|Israel|Korea, Republic of|Poland|Russian Federation|Spain|Sweden|Taiwan|Turkey|United Kingdom 1
United States|Australia|Belgium|France|Germany|Italy|Korea, Republic of|Peru|Spain|Switzerland|Turkey|United Kingdom 1
United States|Australia|Belgium|France|Germany|Italy|Netherlands|Puerto Rico|United Kingdom 1
United States|Australia|Belgium|Hungary|India|Poland|Singapore|Spain|Taiwan|Turkey 1
United States|Australia|Brazil|Canada 1
United States|Australia|Brazil|Canada|China|Czechia|France|Germany|Greece|Hungary|Italy|Japan|Korea, Republic of|Puerto Rico|Russian Federation|Spain|Taiwan|Turkey|United Kingdom 1
United States|Australia|Brazil|Canada|China|Czechia|France|Germany|Israel|Italy|Japan|Korea, Republic of|Russian Federation|Spain|Switzerland|Taiwan|United Kingdom 1
United States|Australia|Brazil|Canada|Denmark|Finland|France|Germany|Italy|Korea, Republic of|Netherlands|Norway|Russian Federation|Spain|Sweden|Taiwan|United Kingdom 1
United States|Australia|Brazil|Czech Republic|France|Israel|Italy|Poland|Puerto Rico|Russian Federation|Ukraine|United Kingdom 1
United States|Australia|Canada|Croatia|Czechia|France|Hungary|Mexico|Poland|Romania|Russian Federation|Serbia|Spain|Taiwan|United Kingdom 1
United States|Australia|Canada|Denmark|Estonia|Finland|France|Germany|Israel|New Zealand|Sweden|United Kingdom 1
United States|Australia|Canada|France|Germany|Italy|Korea, Republic of|Netherlands|Portugal|Spain|Switzerland|United Kingdom 1
United States|Australia|Canada|France|Germany|Italy|Korea, Republic of|Spain|United Kingdom 1
United States|Australia|Canada|France|Germany|Italy|Spain 1
United States|Australia|Canada|France|Germany|Korea, Republic of|Spain|United Kingdom 1
United States|Australia|Canada|France|Germany|Netherlands|Switzerland|United Kingdom 1
United States|Australia|Canada|France|Germany|Poland|United Kingdom 1
United States|Australia|Canada|France|Italy|Korea, Republic of|United Kingdom 1
United States|Australia|Canada|Germany|Japan 1
United States|Australia|Canada|Ireland|Italy|Netherlands|Spain 1
United States|Australia|Canada|Israel 1
United States|Australia|Canada|Italy|Puerto Rico|United Kingdom 1
United States|Australia|Canada|New Zealand|Puerto Rico|Switzerland 1
United States|Australia|Canada|New Zealand|Saudi Arabia 1
United States|Australia|Canada|Puerto Rico|Switzerland 1
United States|Australia|Finland|France|Germany|Netherlands|Spain|United Kingdom 1
United States|Australia|Finland|Italy|Singapore|Spain|Switzerland 1
United States|Australia|France 1
United States|Australia|France|Germany 1
United States|Australia|France|Germany|Israel|Korea, Republic of|Spain 1
United States|Australia|France|Germany|Italy|Japan|Korea, Republic of|Netherlands|Singapore|Spain 1
United States|Australia|France|Germany|Italy|Japan|Netherlands 1
United States|Australia|France|Germany|Italy|Japan|Romania|Spain|United Kingdom 1
United States|Australia|France|Spain 1
United States|Australia|Germany 1
United States|Australia|Germany|Italy 1
United States|Australia|Germany|United Kingdom 1
United States|Australia|Ireland 1
United States|Australia|Israel|Poland|Ukraine 1
United States|Australia|Italy|New Zealand|Spain 1
United States|Australia|New Zealand 1
United States|Australia|Singapore 1
United States|Austria 1
United States|Austria|Belgium|Canada|Denmark|Finland|France|Germany|Greece|Ireland|Israel|Italy|Netherlands|Norway|Portugal|Puerto Rico|Spain|Sweden|Switzerland|Turkey|United Kingdom 1
United States|Austria|Belgium|Canada|France|Germany|Hungary|Italy|Korea, Republic of|Spain|Sweden|Switzerland|Thailand|United Kingdom 1
United States|Austria|Belgium|Canada|France|Germany|Italy|Netherlands|Poland|Portugal|Spain|United Kingdom 1
United States|Austria|Belgium|Czech Republic|France|Germany|Ireland|Italy|Netherlands|Sweden|United Kingdom 1
United States|Austria|Belgium|Czechia|France|Germany|Italy|Netherlands|United Kingdom 1
United States|Austria|Belgium|France|Germany|Hungary|Italy|Poland|Spain|Sweden|Switzerland|United Kingdom 1
United States|Austria|Bulgaria|Canada|Croatia|France|Germany|Greece|Italy|Poland|Portugal|Romania|Russian Federation|Sweden|Ukraine 1
United States|Austria|Canada|France|Germany|Italy|Netherlands 1
United States|Austria|France|Germany|Italy|Norway|Spain|Sweden 1
United States|Austria|Germany|Italy|Poland|United Kingdom 1
United States|Austria|Germany|Italy|Spain 1
United States|Austria|Germany|Poland|Spain 1
United States|Belgium|Brazil|France|Peru|United Kingdom 1
United States|Belgium|Bulgaria|Canada|Czechia|France|Germany|Ireland|Israel|Italy|Netherlands|Spain 1
United States|Belgium|Canada|Croatia|France|Germany|Israel|Italy|Netherlands|Portugal|Spain|Sweden|United Kingdom 1
United States|Belgium|Canada|Czechia|Denmark|France|Israel|Netherlands|Poland|Russian Federation|Spain|Sweden|Turkey|United Kingdom 1
United States|Belgium|Canada|Czechia|France|Germany|Ireland|Israel|Italy|Norway|Poland|Serbia|Spain|United Kingdom 1
United States|Belgium|Canada|Denmark|Finland|France|Germany|Italy|Netherlands|Norway|Spain|United Kingdom 1
United States|Belgium|Canada|Denmark|France|Germany|Hungary|Italy|Japan|Korea, Republic of|Poland|Spain|Sweden|Ukraine|United Kingdom 1
United States|Belgium|Canada|France|Germany|Greece|Netherlands|Poland|Serbia|United Kingdom 1
United States|Belgium|Canada|France|Germany|Israel|Italy|Japan|Korea, Republic of|Poland|Spain|Taiwan|Turkey|United Kingdom 1
United States|Belgium|Canada|France|Germany|Israel|Italy|Poland 1
United States|Belgium|Canada|France|Germany|United Kingdom 1
United States|Belgium|Czech Republic|France|Serbia|United Kingdom 1
United States|Belgium|Czech Republic|Greece|Italy|Poland|Russian Federation|Spain 1
United States|Belgium|Czechia|France|Hungary|India|Italy|Korea, Republic of|Romania|Spain|United Kingdom 1
United States|Belgium|Denmark|France|Israel|Italy|Netherlands|Spain|Sweden 1
United States|Belgium|France|Germany 1
United States|Belgium|France|Germany|Greece|Israel|Italy|Lithuania|Portugal|Spain 1
United States|Belgium|France|Germany|Israel|Italy|Netherlands|Spain|Sweden|United Kingdom 1
United States|Belgium|France|Italy|Netherlands 1
United States|Belgium|France|Italy|Netherlands|Spain 1
United States|Brazil|Bulgaria|Canada|Germany|Greece|India|Italy|Mexico|Netherlands|Poland|Romania|Russian Federation|Spain|Taiwan|Thailand|Ukraine|United Kingdom 1
United States|Brazil|Canada|Czechia|Denmark|France|Germany|Greece|Hungary|Israel|Italy|Japan|Korea, Republic of|Poland|Portugal|Romania|Serbia|Spain|Sweden|Taiwan|United Kingdom 1
United States|Brazil|Denmark|France|Germany|Hong Kong|Italy|Korea, Republic of|Puerto Rico|Taiwan|United Kingdom 1
United States|Brazil|France|Israel|Italy|Netherlands|Portugal|Singapore|Spain|United Kingdom 1
United States|Brazil|France|Italy|Korea, Republic of|Netherlands|Russian Federation|United Kingdom 1
United States|Canada|Australia|Belgium|Denmark|France|Germany|Greece|Italy|Japan|Korea, Republic of|New Zealand|Poland|Spain|Taiwan|United Kingdom 1
United States|Canada|Denmark|France|Germany|Israel|Italy|Netherlands|Poland|Spain|United Kingdom 1
United States|Canada|Finland|France|Germany|Italy|United Kingdom 1
United States|Canada|France|Germany|Italy 1
United States|Canada|France|Germany|Italy|Netherlands|Poland|Spain|United Kingdom 1
United States|Canada|France|Germany|Italy|Spain|Sweden|United Kingdom 1
United States|Canada|France|Germany|Netherlands 1
United States|Canada|France|Italy 1
United States|Canada|France|Italy|Norway|Spain|United Kingdom 1
United States|Canada|France|Italy|United Kingdom 1
United States|Canada|France|Netherlands|Spain|United Kingdom 1
United States|Canada|France|Poland 1
United States|Canada|France|Spain 1
United States|Canada|Georgia|Moldova, Republic of|Poland|Spain|Ukraine 1
United States|Canada|Germany|Israel|United Kingdom 1
United States|Canada|Germany|Italy|Poland|Spain 1
United States|Canada|Germany|Italy|Spain|Sweden|United Kingdom 1
United States|Canada|Germany|Poland|Switzerland 1
United States|Canada|Israel|Puerto Rico 1
United States|Canada|Netherlands 1
United States|Canada|New Zealand 1
United States|Canada|Puerto Rico|South Africa 1
United States|Canada|Sweden 1
United States|Denmark 1
United States|Denmark|France|United Kingdom 1
United States|Denmark|Italy 1
United States|Egypt|India 1
United States|Egypt|Singapore 1
United States|France|Australia|Austria|Belgium|Brazil|Canada|China|Croatia|Czechia|Denmark|Finland|Germany|Hungary|Israel|Italy|Japan|Korea, Republic of|Norway|Poland|Portugal|Puerto Rico|Russian Federation|South Africa|Spain|Sweden|Taiwan|Turkey|Ukraine 1
United States|France|Germany|Italy 1
United States|France|Germany|Italy|Japan|Netherlands|United Kingdom 1
United States|France|Germany|Italy|Korea, Republic of 1
United States|France|Germany|Italy|Spain|United Kingdom 1
United States|France|Germany|Italy|Switzerland|United Kingdom 1
United States|France|Germany|Norway 1
United States|France|Germany|Spain 1
United States|France|Hungary|Italy|Japan|Korea, Republic of|Malaysia|Netherlands|Russian Federation|Spain|Thailand|Turkey|United Kingdom 1
United States|France|Italy|Netherlands 1
United States|France|Italy|Spain 1
United States|France|Italy|United Kingdom 1
United States|France|Japan|United Kingdom 1
United States|France|Spain|United Kingdom 1
United States|France|United Kingdom 1
United States|Germany|Ireland|Israel 1
United States|Germany|Israel 1
United States|Germany|United Kingdom 1
United States|Hungary|Israel|Italy|Spain 1
United States|India|Israel 1
United States|Israel|Italy|Poland|Russian Federation|Spain|United Kingdom 1
United States|Israel|Peru 1
United States|Italy|Netherlands|Singapore|Spain 1
United States|Italy|United Kingdom 1
United States|Japan 1
United States|New Zealand 1
United States|Singapore 1
United States|Spain|United Kingdom 1
United States|Sweden 1

Sites per Study

Site_count Study_Count
1 1619
2 218
3 145
4 96
5 93
6 74
7 51
8 54
9 50
10 43
11 41
12 31
13 29
14 19
15 21
16 16
17 21
18 17
19 15
20 19
21 19
22 21
23 19
24 14
25 13
26 9
27 11
28 10
29 5
30 8
31 7
32 8
33 12
34 13
35 7
36 8
37 1
38 8
39 4
40 2
41 2
42 6
43 7
44 4
45 4
46 5
47 2
48 2
49 1
50 10
51 4
52 6
53 6
54 5
55 4
56 3
57 3
58 3
59 2
60 2
61 5
62 4
63 1
64 1
65 4
66 4
67 1
69 3
70 2
71 3
72 2
73 3
75 1
76 4
78 3
79 2
80 2
81 5
82 2
83 1
84 2
85 5
86 3
87 3
88 3
90 1
91 3
92 2
94 1
95 1
96 2
97 3
98 1
99 4
100 1
101 3
102 1
103 1
105 1
106 2
107 2
108 3
109 2
110 1
111 2
112 2
115 1
117 3
118 2
119 4
120 1
122 2
123 3
124 1
125 1
127 1
128 2
130 2
131 2
132 1
134 1
135 3
137 1
139 2
140 1
143 1
144 1
145 1
148 1
149 1
150 2
151 1
153 2
157 1
160 3
161 1
162 1
163 1
165 1
166 1
169 1
170 1
171 2
172 1
173 2
174 2
176 1
177 1
178 1
179 1
185 2
186 1
187 1
188 1
192 2
196 1
198 2
199 1
201 1
210 1
211 1
212 1
215 1
218 2
220 2
224 1
225 1
228 1
233 1
234 1
235 2
237 1
239 1
241 1
242 1
244 2
262 3
269 1
279 1
298 1
299 1
326 1
341 2
364 1
447 1
454 1
551 1
747 1
796 1
837 1
954 1

Phase

Phase Study_Count
Phase 2 1201
Phase 1 819
Phase 1/Phase 2 467
Phase 3 341
N/A 191
Phase 4 70
Phase 2/Phase 3 61
Early Phase 1 27

Number of Arms

Number_of_Arms Count_of_Studies
1 1621
2 690
3 161
4 95
5 30
6 32
7 15
8 5
9 7
10 8
11 2
12 3
13 1
16 1
17 1
21 1
NA 504

Enrollment Metrics by Phase

Measure Early.Phase.1 N.A Phase.1 Phase.1.Phase.2 Phase.2 Phase.2.Phase.3 Phase.3 Phase.4
Min. 4.00000 2.0000 1.00000 1.00000 1.00000 9.0000 6.000 10.0000
1st Qu. 12.50000 26.0000 18.00000 30.00000 30.00000 47.0000 174.000 58.0000
Median 20.00000 52.5000 30.00000 45.00000 50.00000 98.0000 350.000 101.0000
Mean 35.77778 185.0645 39.77792 68.23318 76.41073 241.7833 589.462 221.4706
3rd Qu. 33.00000 108.2500 49.75000 75.00000 92.00000 200.5000 578.000 206.2500
Max. 312.00000 4000.0000 746.00000 2000.00000 862.00000 2000.0000 9350.000 2600.0000

Trial Group Type

group_type Group_Count
Experimental 3853
NA 504
Active Comparator 464
Other 144
No Intervention 93
Placebo Comparator 63
Sham Comparator 2

Intervention Model

intervention_model Study_Count
Single Group Assignment 1946
Parallel Assignment 791
NA 289
Sequential Assignment 100
Crossover Assignment 33
Factorial Assignment 18

Primary Purpose

primary_purpose Study_Count
Treatment 2912
Supportive Care 123
Prevention 60
NA 23
Other 20
Basic Science 16
Health Services Research 11
Diagnostic 10
Device Feasibility 1
Screening 1

Observational Studies

Studies by Country

Country Study_Count
United States 143
NA 78
France 30
Italy 23
China 13
Israel 10
Spain 10
Korea, Republic of 9
Denmark 7
Russian Federation 7
Canada 6
United Kingdom 6
Egypt 5
Germany 4
Greece 4
Mexico 3
Sweden 3
United States|Australia|Canada 3
Australia 2
Belgium 2
Brazil 2
India 2
Ireland|United Kingdom 2
Japan 2
Taiwan 2
Turkey 2
United States|Australia|Canada|New Zealand|Puerto Rico|Switzerland 2
United States|Canada 2
United States|Puerto Rico 2
Argentina 1
Argentina|Brazil|Chile|Colombia|Guatemala|Mexico|Panama 1
Austria 1
Austria|Croatia 1
Austria|Germany 1
Austria|Germany|Italy 1
Austria|Germany|Switzerland 1
Belgium|Croatia|France|Italy|North Macedonia|Slovakia|Slovenia|Turkey 1
Belgium|France|Portugal 1
Canada|Korea, Republic of 1
Czech Republic|France|Germany|Italy|Poland|Russian Federation|Spain|United Kingdom 1
Czechia 1
Denmark|Finland|Iceland|Lithuania|Norway|Sweden 1
Denmark|Finland|Iceland|Norway|Sweden 1
Denmark|France|Germany|Israel|Italy|Netherlands|Poland|Russian Federation|Spain 1
France|Germany|Italy|Spain 1
Germany|Hungary|Denmark|Finland|Israel|Poland|Russian Federation|Saudi Arabia|United Kingdom 1
Guadeloupe|Martinique 1
Guatemala 1
Hong Kong 1
Hungary 1
Indonesia 1
Italy|Switzerland 1
Jordan 1
Serbia 1
Switzerland 1
Ukraine 1
United States|Australia|Canada|Ireland|New Zealand|Puerto Rico|Switzerland 1
United States|Australia|Canada|New Zealand 1
United States|Australia|Canada|Puerto Rico 1
United States|Australia|Canada|Puerto Rico|Switzerland 1
United States|Austria|Belgium|France|Germany|Greece|Iraq|Italy|Netherlands|Taiwan 1
United States|Austria|Brazil|China|Germany|Iraq|Italy|Malaysia|Netherlands 1
United States|Belgium|Canada|Germany|Netherlands|United Kingdom 1
United States|Canada|Germany 1
United States|Canada|Puerto Rico|Switzerland 1
United States|Czech Republic|France|Germany|Italy|Poland|Spain|United Kingdom 1
United States|France|Germany|Italy|Netherlands|Puerto Rico|Russian Federation|Spain 1
United States|Netherlands 1
United States|Taiwan 1

Sites per Study

Site_count Study_Count
1 285
2 23
3 12
4 4
5 6
6 3
7 5
8 2
9 2
10 3
11 1
12 1
13 2
14 4
15 2
16 1
17 4
18 1
19 4
20 2
21 1
25 2
26 1
28 1
31 3
32 2
33 2
34 1
35 1
37 2
38 2
39 2
40 1
41 2
42 1
43 1
46 2
47 1
49 1
50 1
51 1
52 1
55 1
56 1
59 1
66 2
70 1
71 1
77 1
79 1
84 1
96 1
112 1
135 1
137 1
142 1
144 1
161 1
165 1
183 1
192 1
200 1
214 1
225 1
244 1
280 1
291 1
292 1

Enrollment Metrics

Measure Observational
Min 1.0000
1st Qu 50.0000
Median 149.0000
Mean 846.9031
3rd Qu 400.0000
Max 99999.0000

Observation Model

observational_model Study_Count
Cohort 214
Case-Only 102
Other 36
NA 27
Case-Control 24
Case Control 15
Family-Based 3
Ecologic or Community 2
Case-Crossover 1
Case Control, Natural History 1
Defined Population, Natural History 1

Time Perspective

time_perspective Study_Count
Prospective 218
Retrospective 148
Cross-Sectional 27
NA 16
Other 15
Cross-Sectional, Retrospective 1
Longitudinal, Prospective 1

Registries

Studies by Country

Country Study_Count
Germany 5
United States 5
France 4
NA 2
Brazil 1
Canada 1
China 1
Czechia 1
Hong Kong 1
Indonesia 1
Italy 1
Sweden 1
Turkey 1
United Kingdom 1

Sites per Study

Site_count Study_Count
1 16
2 3
6 1
7 1
11 1
27 1
34 1
51 1
192 1

Enrollment Metrics

Measure Registries
Min 24.000
1st Qu 200.000
Median 494.000
Mean 2613.885
3rd Qu 2750.000
Max 27000.000

Registry Model

observational_model Study_Count
Cohort 14
Other 8
Case-Only 3
Case Control 1

Time Perspective

time_perspective Study_Count
Prospective 19
Other 4
Cross-Sectional 3

Follow-up

target_duration Study_Count
10 Years 7
5 Years 6
1 Year 3
2 Years 3
1 Day 1
12 Months 1
15 Years 1
20 Years 1
25 Years 1
3 Years 1
4 Years 1

Overview of Studies

Interventional Trials

#If less then 500 trials

Observational Studiess

#If less then 500 studies

nct_id brief_title link overall_status source primary_completion_date
NCT04456959 InO - A Retrospective Study of UK Patients With Leukaemia https://ClinicalTrials.gov/show/NCT04456959 Recruiting Pfizer 2020-12-31
NCT04454580 Hypomethylating Agents and Venetoclax in Newly Diagnosed Acute Myeloid Leukemia Patients Not Eligible for Intensive Chemotherapy https://ClinicalTrials.gov/show/NCT04454580 Recruiting Ospedale Maggiore Di Trieste 2020-07-23
NCT03627208 Optimal Methods of Disease Detection in Children and Young Adults With Acute Lymphoblastic Leukemia in the Pediatric Oncology Branch https://ClinicalTrials.gov/show/NCT03627208 Enrolling by invitation National Institutes of Health Clinical Center (CC) 2021-12-31
NCT03374137 Observational Study to Monitor Safety and Effectiveness of Obinutuzumab in Follicular Lymphoma or Previously Untreated Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT03374137 Recruiting Hoffmann-La Roche 2020-09-30
NCT03342144 Study of the Use of Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) Under Real-Life Setting https://ClinicalTrials.gov/show/NCT03342144 Recruiting AbbVie 2022-12-31
NCT03316456 Gut Microbiota in Intestinal Barrier Damage in Acute Leukemia Patients Undergoing Inpatient Induction https://ClinicalTrials.gov/show/NCT03316456 Completed Masonic Cancer Center, University of Minnesota 2017-12-26
NCT03311815 Diagnostic Platform to Perform Centralized and Standardized Rapid Molecular Diagnosis by Next Generation Sequencing (NGS) in Patients Diagnosed With Acute Myeloid Leukemia. https://ClinicalTrials.gov/show/NCT03311815 Recruiting PETHEMA Foundation 2020-09-30
NCT03289182 An Observational Study of MabThera Subcutaneous (SC) Safety in Participants With Non-Hodgkin’s Lymphoma (NHL) or Chronic Lymphocytic Leukemia (CLL) https://ClinicalTrials.gov/show/NCT03289182 Active, not recruiting Hoffmann-La Roche 2020-10-26
NCT03284593 Prognostic Factors and the Impact of Various Management of Acute Myeloid Leukemia in Real Life Condition https://ClinicalTrials.gov/show/NCT03284593 Active, not recruiting University Hospital, Toulouse 2030-12-31
NCT03279900 Hematotoxicity in Acute Lymphoblastic Leukemia Children in Maintenance Phase Therapy https://ClinicalTrials.gov/show/NCT03279900 Completed Indonesia University 2018-05-16
NCT03260101 Non-interventional, Long-term Follow-up of Subjects Who Completed ApoGraft-01 Study https://ClinicalTrials.gov/show/NCT03260101 Recruiting Cellect Biotechnology 2021-12-31
NCT03253848 Simplified Patient Care Strategy in Decreasing Early Death in Patients With Acute Promyelocytic Leukemia https://ClinicalTrials.gov/show/NCT03253848 Recruiting Eastern Cooperative Oncology Group 2022-08-18
NCT03251352 TKI Discontinuation in CML Patients of China https://ClinicalTrials.gov/show/NCT03251352 Recruiting Shenzhen Second People’s Hospital 2020-09-30
NCT03226704 Leukapheresis for CAR-Therapy Manufacturing https://ClinicalTrials.gov/show/NCT03226704 Recruiting National Institutes of Health Clinical Center (CC) 2023-05-01
NCT03233763 Laboratory Studies Into the Pathology of Leukaemia https://ClinicalTrials.gov/show/NCT03233763 Recruiting Royal Marsden NHS Foundation Trust 2021-02-01
NCT03190499 Quality of Life in Children With Cancer https://ClinicalTrials.gov/show/NCT03190499 Completed Cumhuriyet University 2018-08-01
NCT03123887 Evaluate the Hematological Remission Rates and Survival Among Chinese Adult Patients With B-precursor ALL https://ClinicalTrials.gov/show/NCT03123887 Completed Harbin Hematology and Oncology Institute 2016-06-03
NCT03075969 Phase IV EORTC Quality of Life Module for Patients With Chronic Myeloid Leukemia https://ClinicalTrials.gov/show/NCT03075969 Active, not recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2019-03-16
NCT03067584 Genetic Study of Familial Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT03067584 Completed St. Jude Children’s Research Hospital 2017-06-23
NCT03058588 Next Generation Sequencing (NGS) in Familial Acute Myeloid Leukemia and Myelodisplastic Syndromes https://ClinicalTrials.gov/show/NCT03058588 Recruiting Azienda Socio Sanitaria Territoriale degli Spedali Civili di Brescia 2021-02-09
NCT03059251 Observational Study: Safety and Effectiveness of Obinutuzumab in Chronic Lymphocytic Leukemia in Argentina https://ClinicalTrials.gov/show/NCT03059251 Completed Hoffmann-La Roche 2019-03-30
NCT03050268 Familial Investigations of Childhood Cancer Predisposition https://ClinicalTrials.gov/show/NCT03050268 Recruiting St. Jude Children’s Research Hospital 2037-03-31
NCT03045120 Determining Change in Cardiovascular and Metabolic Risks in Patients With Chronic Phase Chronic Myeloid Leukemia Receiving BCR-ABL Tyrosine Kinase Inhibitor First-Line Therapy in the United States https://ClinicalTrials.gov/show/NCT03045120 Recruiting Bristol-Myers Squibb 2021-01-31
NCT03000335 Evaluation of ProALL miRs in Blood Specimen for Prediction of ALL Relapse Risk https://ClinicalTrials.gov/show/NCT03000335 Recruiting Curewize Health Ltd. 2020-05-31
NCT02991066 Role of Microparticles in the Coagulopathy of Acute Promyelocytic Leukemia https://ClinicalTrials.gov/show/NCT02991066 Recruiting First Affiliated Hospital of Harbin Medical University 2019-12-31
NCT02981784 Comparative Evaluation of Results of Allogeneic Hematopoietic Stem Cells Versus Ponatinib in CML Patients Carrying a Mutation T315I https://ClinicalTrials.gov/show/NCT02981784 Completed Hospices Civils de Lyon 2011-12-31
NCT02977312 Study of Cemivil® (Imatinib) in Chronic Myeloid Leukemia Patients in Jordan https://ClinicalTrials.gov/show/NCT02977312 Completed Hikma Pharmaceuticals LLC 2015-02-28
NCT02921815 A Study to Analyze the Occurrence of Transformation From Myelodysplastic Syndrome to Acute Myeloid Leukemia in Patients With Myelodysplastic Syndrome Who Received Revlimid® 5 mg Capsules and Who Are Continuing or no Longer Continuing Revlimid Treatment https://ClinicalTrials.gov/show/NCT02921815 Active, not recruiting Celgene 2020-06-19
NCT02927106 Beat AML Core Study https://ClinicalTrials.gov/show/NCT02927106 Recruiting University of Florida 2024-02-15
NCT02899767 Transfusion in Adult Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT02899767 Completed Hospices Civils de Lyon 2014-12-31
NCT02900430 Invasives Aspergillosis in Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT02900430 Completed University Hospital, Brest 2015-12-31
NCT02896829 Follow-up of the Persistence of the Complete Molecular Remission After Stopping Imatinib Chronic Myeloid Leukemia https://ClinicalTrials.gov/show/NCT02896829 Completed University Hospital, Bordeaux 2019-04-30
NCT02895542 Preparatory Work to Assess Adherence to Oral Chemotherapy https://ClinicalTrials.gov/show/NCT02895542 Completed Wake Forest University Health Sciences 2017-04-28
NCT02891551 An Observational Post Authorisation Study to Evaluate Safety and Efficacy in Patients Receiving Azacitidine in Daily Clinical Practice in the Netherlands https://ClinicalTrials.gov/show/NCT02891551 Completed Celgene 2016-06-30
NCT02883946 Rituximab in Hairy Cell Leukemia: a Multicenter Retrospective Study https://ClinicalTrials.gov/show/NCT02883946 Completed CHU de Reims 2013-02-28
NCT02888977 Tyrosine Kinase Inhibitors and Low Intensity Chemotherapy in Ph+ ALL https://ClinicalTrials.gov/show/NCT02888977 Recruiting Versailles Hospital 2020-12-31
NCT02869256 Regional Central Database Recording of Chronic Myeloid Leukemia https://ClinicalTrials.gov/show/NCT02869256 Recruiting Institut Bergonié 2024-01-31
NCT02861651 Molecular Characterization of Acute Erythroid Leukemia (M6-AML) Using Targeted Next-generation Sequencing https://ClinicalTrials.gov/show/NCT02861651 Completed Institut Paoli-Calmettes 2015-07-31
NCT02859389 Neurocognitive and Psychosocial Outcomes in Survivors of Childhood Leukemia With Down Syndrome https://ClinicalTrials.gov/show/NCT02859389 Completed St. Jude Children’s Research Hospital 2019-01-31
NCT02845232 Economic Analysis of Blood Product Transfusions According to the Treatment of Acute Myeloid Leukaemia in the Elderly https://ClinicalTrials.gov/show/NCT02845232 Completed Hospices Civils de Lyon 2014-12-31
NCT02844257 Transfusion Dependency at Diagnosis and Transfusion Intensity During Initial Chemotherapy Are Associated With Poorer Outcomes in Adult Acute Myeloid Leukaemia https://ClinicalTrials.gov/show/NCT02844257 Completed Hospices Civils de Lyon 2014-12-31
NCT02844218 Effect of Age on Treatment Decision-Making in Elderly Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT02844218 Completed Hospices Civils de Lyon 2014-12-31
NCT02842229 A Study to Determine Final Geriatric Assessment in Haematology (GAH) Score as a Tool for Predicting Tolerance to Treatment in Elderly Patients (≥ 65 Years) With Haematologic Neoplasms https://ClinicalTrials.gov/show/NCT02842229 Completed Celgene 2017-02-02
NCT02842112 Higher Percentage of CD34+ CD38- Cells Detected by Multiparameter Flow Cytometry From Leukapheresis Products Predicts Unsustained Complete Remission in Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT02842112 Completed Hospices Civils de Lyon 2013-12-31
NCT02827617 Identification of Biomarkers That Are Predictive of Early Ibrutinib Treatment Failure in High Risk TP53 Mutated Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT02827617 Recruiting Oncology Institute of Southern Switzerland 2021-02-28
NCT02823132 Study of the Level of a Protein Which Could Predict the Development of a Fungal Infection in Patients With Acute Leukemia https://ClinicalTrials.gov/show/NCT02823132 Completed Centre Hospitalier Universitaire Dijon 2015-06-30
NCT02783651 An Study of Patients With Ph- Chromosome-negative Relapsed or Refractory Acute Lymphoblastic Leukemia in the US https://ClinicalTrials.gov/show/NCT02783651 Completed Amgen 2020-03-31
NCT02774850 Home Away From Home - Medical Outcomes https://ClinicalTrials.gov/show/NCT02774850 Completed Children’s Hospital of Philadelphia 2019-07-26
NCT02767388 Electrophysiological Biomarkers of Chemotherapy-related Cognitive Impairment and Recovery https://ClinicalTrials.gov/show/NCT02767388 Completed University of Nebraska 2017-12-11
NCT02759822 Haploidentical Hematopoietic Stem Cell Transplantation for Acute Leukemias https://ClinicalTrials.gov/show/NCT02759822 Recruiting Instituto Nacional de Cancer, Brazil 2021-04-30
NCT02734823 Long Term Effects of Tyrosine Kinase Inhibitor Therapy on Ovarian Reserve and Fertility in Patients With Chronic Myeloid Leukemia or Gastrointestinal Stromal Tumor https://ClinicalTrials.gov/show/NCT02734823 Recruiting University of Southern California 2020-03-01
NCT02714790 Prognostic Role of Minimal Residual Disease in Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT02714790 Completed Azienda Ospedaliera Città della Salute e della Scienza di Torino 2015-06-30
NCT02693899 Prospective Study on the Feasibility of Plasma FLT3-Ligand Assay to Achieve a First Estimate of Its Prognostic Value on the Outcome of Patients Treated Intensively for Acute Leukemia https://ClinicalTrials.gov/show/NCT02693899 Completed Nantes University Hospital 2018-02-06
NCT02677064 Identify Barriers to Allogeneic Hematopoietic Stem Cell Transplantation in Patients With Newly Diagnosed and Relapsed Acute Leukemia https://ClinicalTrials.gov/show/NCT02677064 Recruiting Memorial Sloan Kettering Cancer Center 2021-02-28
NCT02667093 Samples From Leukemia Patients and Their Donors to Identify Specific Antigens https://ClinicalTrials.gov/show/NCT02667093 Active, not recruiting PersImmune, Inc 2020-12-31
NCT02662920 Investigating the Prevalence and Prognostic Importance of Polypharmacy in Adults Treated for Newly Diagnosed Acute Myelogenous Leukemia (AML) https://ClinicalTrials.gov/show/NCT02662920 Completed Wake Forest University Health Sciences 2014-04-30
NCT02631993 Photochemotherapy and Graft-versus-leukemia in Acute-leukemia https://ClinicalTrials.gov/show/NCT02631993 Completed Karolinska University Hospital 2014-11-30
NCT02617004 Multicenter Trial Treatment of Philadelphia Chromosome Negative B-cell Acute Lymphoblastic Leukemia of Young Adults https://ClinicalTrials.gov/show/NCT02617004 Recruiting Assistance Publique - Hôpitaux de Paris 2020-12-31
NCT02606825 VILMA: Therapeutic Results in Acute Mieloblastic Leukemia in Patients Older Than 60 Years https://ClinicalTrials.gov/show/NCT02606825 Completed PETHEMA Foundation 2018-02-15
NCT02598752 Feasibility and Safety of Functional Performance Testing in Patients Undergoing Hematopoietic Cell Transplantation https://ClinicalTrials.gov/show/NCT02598752 Completed Memorial Sloan Kettering Cancer Center 2020-04-10
NCT02582320 Clinical-biological Characteristics and Outcome of Chronic Lymphocytic Leukemia Under Ibrutinib-named Patient Program https://ClinicalTrials.gov/show/NCT02582320 Recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2018-12-31
NCT00923442 Biology Studies of Hematologic Cancers https://ClinicalTrials.gov/show/NCT00923442 Enrolling by invitation National Institutes of Health Clinical Center (CC) NA
NCT01351545 A Multicenter Access and Distribution Protocol for Unlicensed Cryopreserved Cord Blood Units (CBUs) https://ClinicalTrials.gov/show/NCT01351545 Recruiting Center for International Blood and Marrow Transplant Research 2021-10-31
NCT00559065 A Case-Cohort Study of Hematopoietic Malignancies and Related Disorders and Lung Cancer in Benzene-Exposed Workers in China https://ClinicalTrials.gov/show/NCT00559065 Completed National Institutes of Health Clinical Center (CC) NA
NCT00342888 Case-Control Study of Pesticides and Childhood Leukemia https://ClinicalTrials.gov/show/NCT00342888 Completed National Institutes of Health Clinical Center (CC) NA
NCT02560883 Clinical Research in Hairy Cell Leukemia:Surveillance and Documentation of Clinical Outcomes https://ClinicalTrials.gov/show/NCT02560883 Recruiting Ohio State University Comprehensive Cancer Center 2025-12-31
NCT00268528 Study to Assess Compliance With Long-Term Mercaptopurine Treatment in Young Patients With Acute Lymphoblastic Leukemia in Remission https://ClinicalTrials.gov/show/NCT00268528 Completed Children’s Oncology Group 2012-03-05
NCT02559583 Observational Study in Participants With Chronic Lymphocytic Leukemia (CLL), Multiple Myeloma (MM) and Non-Hodgkin’s Lymphoma (NHL) in Latin America https://ClinicalTrials.gov/show/NCT02559583 Completed Janssen-Cilag Ltd. 2016-06-30
NCT02546791 Frequency and Severity of Pleural Effusion Associated With the Use of Dasatinib in Patients With Chronic Myeloid Leukemia. A Descriptive, Mexican Multicenter Study https://ClinicalTrials.gov/show/NCT02546791 Completed Bristol-Myers Squibb 2016-11-30
NCT02028650 Randomized Study of HLA-mismatched DSI to Treat Relapse Leukemia After HLA- Matched Transplantation https://ClinicalTrials.gov/show/NCT02028650 Completed The Affiliated Hospital of the Chinese Academy of Military Medical Sciences 2013-02-28
NCT02527447 Biomarkers for Personalized Early Assessment of Response During Salvage Chemotherapy in People With Relapsed or Refractory Acute Myeloid Leukemia (PEARL15) https://ClinicalTrials.gov/show/NCT02527447 Completed National Institutes of Health Clinical Center (CC) 2018-05-10
NCT02520895 Immunological Repertoire in Patients With Lymphoma and Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT02520895 Completed Hospices Civils de Lyon 2013-10-31
NCT02491398 Efficacy and Safety of Bendamustine Plus Rituximab in Chronic Lympocytic Leukemia https://ClinicalTrials.gov/show/NCT02491398 Active, not recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2018-10-31
NCT02461316 Rituximab in Combination With Fludarabine and Cyclophosphamide in Patients With Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT02461316 Completed Hoffmann-La Roche 2011-12-31
NCT02455024 An Observational Registry to Evaluate the Incidence of and Risk Factors for Vascular Occlusive Events Associated With ICLUSIG® https://ClinicalTrials.gov/show/NCT02455024 Recruiting Takeda 2020-09-30
NCT02451592 Fungemia in Hematologic Malignancies https://ClinicalTrials.gov/show/NCT02451592 Completed Sorveglianza Epidemiologica Infezioni Fungine Emopatie Maligne 2015-12-31
NCT02414022 Economic Analysis of Alliance A041202 CLL Study https://ClinicalTrials.gov/show/NCT02414022 Active, not recruiting Canadian Cancer Trials Group 2019-04-05
NCT02389972 Effectiveness of Dasatinib in Adult Patients With Chronic Myeloid Leukemia in China: A Multicenter, Registry Study https://ClinicalTrials.gov/show/NCT02389972 Completed Bristol-Myers Squibb 2017-07-13
NCT02381899 Observational Study in CLL Patients Receiving BR https://ClinicalTrials.gov/show/NCT02381899 Completed Czech CLL Study Group 2016-12-31
NCT02378701 Interventional Validation of an MDS-Specific Measure of Quality of Life: Assessing the Responsiveness of the Quality of Life in Myelodysplasia Scale (QUALMS-1) to Different Hypomethylating Agent Regimens for Low and Intermediate Risk Disease https://ClinicalTrials.gov/show/NCT02378701 Active, not recruiting M.D. Anderson Cancer Center 2023-02-28
NCT02363868 Healthcare Costs Among Patients With CML Receiving Dasatinib or Nilotinib in a Commercial and Medicare Population https://ClinicalTrials.gov/show/NCT02363868 Completed Bristol-Myers Squibb 2014-11-30
NCT02348957 Treating Patients With Chronic Myeloid Leukemia (CML) in Chronic Phase (CP) With Dasatinib https://ClinicalTrials.gov/show/NCT02348957 Completed Onco Medical Consult GmbH 2019-03-31
NCT02344953 Prospective and Retrospective Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia (Acute Leukemia HSCT Cohort) https://ClinicalTrials.gov/show/NCT02344953 Recruiting Yonsei University 2020-12-31
NCT02338479 Natural History and Biology of Long-Term Late Effects Following Hematopoietic Cell Transplant for Childhood Hematologic Malignancies https://ClinicalTrials.gov/show/NCT02338479 Active, not recruiting Center for International Blood and Marrow Transplant Research 2020-02-29
NCT02303522 Historical Data Analysis of Complete Remission in Children With R/R Acute Lymphoblastic Leukemia (ALL) https://ClinicalTrials.gov/show/NCT02303522 Completed Amgen 2015-01-22
NCT02269592 Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome https://ClinicalTrials.gov/show/NCT02269592 Recruiting Dana-Farber Cancer Institute 2024-12-31
NCT02272673 The Effects of Honey on Febrile Neutropenia in Children With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT02272673 Completed Ain Shams University 2013-08-31
NCT02222272 Effect of 2nd Gen TKI in CML https://ClinicalTrials.gov/show/NCT02222272 Completed European Group for Blood and Marrow Transplantation 2014-03-19
NCT02164903 LEONIDAS: Quality of Life Study in Chronic Myeloid Leukemia Patients https://ClinicalTrials.gov/show/NCT02164903 Active, not recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2017-01-25
NCT02110394 Ribomustin in the First Line Therapy of Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT02110394 Completed Astellas Pharma Inc 2015-08-31
NCT02085798 Health Outcomes of Recently Diagnosed Myelodysplastic Syndrome (MDS)/Chronic Myelomonocytic Leukemia (CMML) Patients Depending on Treatment Strategy (Wait and See, Support, Active Treatment) https://ClinicalTrials.gov/show/NCT02085798 Completed Celgene 2015-08-31
NCT02080884 An Observational Study Examining the Effect of Added MabThera Therapy in Patients With Untreated Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT02080884 Completed Hoffmann-La Roche 2016-12-19
NCT01311258 Monitoring Minimal Residual Disease of Patients With Acute Myelogenous Leukemia or High Grade Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT01311258 Recruiting University of Rochester 2020-08-31
NCT01298414 Biomarkers in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01298414 Completed Children’s Oncology Group 2016-05-31
NCT01295476 Biomarker Study in Bone Marrow Samples From Patients With T-Cell Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01295476 Completed Children’s Oncology Group 2013-05-31
NCT01290107 Biomarkers in Samples of Bone Marrow From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01290107 Completed Children’s Oncology Group 2015-01-31
NCT01284010 Biomarkers in Blood and Bone Marrow Samples From Patients With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01284010 Completed Alliance for Clinical Trials in Oncology 2014-09-30
NCT01278069 PET-CT in AML for Detection of Extramedullary AML Manifestations https://ClinicalTrials.gov/show/NCT01278069 Completed Technische Universität Dresden 2013-09-30
NCT02057185 Occupational Status and Hematological Disease https://ClinicalTrials.gov/show/NCT02057185 Active, not recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2019-03-31
NCT02016833 Development of Immunological Assays for the Evaluation of Tumor Antigen Specific Immunity https://ClinicalTrials.gov/show/NCT02016833 Completed PX Biosolutions 2014-06-30
NCT03310190 Study to Describe the Management and the Use of Healthcare Resources in Patients With Chronic Lymphocytic Leukemia (CLL) Initiating Venetoclax in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT03310190 Recruiting AbbVie 2021-06-30
NCT02010931 Retrospective Analysis of Survival in Adult MRD Positive Acute Lymphoblastic Leukemia Patients https://ClinicalTrials.gov/show/NCT02010931 Completed Amgen 2014-03-31
NCT02003612 Historical Data Analysis of Hematological Remission and Survival in Adults With R/R Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT02003612 Completed Amgen 2014-01-31
NCT01999556 LCI-HEM-SPEC-001: Tissue Collection for Genetic Analysis of Acute Myelogenous Leukemia https://ClinicalTrials.gov/show/NCT01999556 Recruiting Atrium Health 2021-09-30
NCT01976442 Use of Saline-Washed Platelet and Red Cell Transfusions in Adult Acute Leukemia https://ClinicalTrials.gov/show/NCT01976442 Completed University of Rochester 2016-11-30
NCT01965171 Transfusional Iron Overload Among Leukemia Survivors https://ClinicalTrials.gov/show/NCT01965171 Completed St. Jude Children’s Research Hospital 2017-05-31
NCT01941680 High Risk Adult T-cell Leukemia/Lymphoma (ATLL-HR) and Allogeneic Transplant https://ClinicalTrials.gov/show/NCT01941680 Active, not recruiting University Hospital Center of Martinique 2018-02-28
NCT01929408 Feasibility and Outcomes of Allogeneic HCT Compared to Chemotherapy in Older AML Patients https://ClinicalTrials.gov/show/NCT01929408 Completed Fred Hutchinson Cancer Research Center 2018-12-04
NCT01913093 N-PhenoGENICS: Neurocognitive-Phenome, Genome, Epigenome and Nutriome In Childhood Leukemia Survivors https://ClinicalTrials.gov/show/NCT01913093 Active, not recruiting The Hospital for Sick Children 2018-01-31
NCT01910623 Long-Term Quality of Life in Patients With Acute Promyelocytic Leukemia https://ClinicalTrials.gov/show/NCT01910623 Completed Gruppo Italiano Malattie EMatologiche dell’Adulto 2014-07-31
NCT01896752 Renal and Hepatic Clearance Following High-Dose Methotrexate in Childhood ALL https://ClinicalTrials.gov/show/NCT01896752 Completed Rigshospitalet, Denmark 2013-01-31
NCT01886651 The Influence of Thiopurine Methyltransferase Activity on Toxicity After High-dose Methotrexate in Childhood Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01886651 Completed Rigshospitalet, Denmark 2012-02-29
NCT01860456 TyrosIne Kinase Inhibitors in Chronic Myeloid Leukemia: Efficacy and Tolerability. The TIKlet Study https://ClinicalTrials.gov/show/NCT01860456 Active, not recruiting University of Pisa 2021-05-31
NCT01805843 Pulmonary Vasculopathy Under Second-line Therapy of Chronic Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01805843 Completed Medical University of Graz 2015-06-30
NCT01790152 Effects of Dexrazoxane Hydrochloride on Biomarkers Associated With Cardiomyopathy and Heart Failure After Cancer Treatment https://ClinicalTrials.gov/show/NCT01790152 Recruiting Children’s Oncology Group 2022-03-30
NCT01761890 Front-line Treatment of BCR-ABL+ Chronic Myeloid Leukemia (CML) With Dasatinib https://ClinicalTrials.gov/show/NCT01761890 Recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2018-12-31
NCT01752062 Observational Study of Conception/Pregnancy in Adult Patients With CML Treated With Tyrosine Kinase Inhibitors https://ClinicalTrials.gov/show/NCT01752062 Recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2018-12-31
NCT01728402 Pathogenesis of Hematologic Malignancies https://ClinicalTrials.gov/show/NCT01728402 Enrolling by invitation OHSU Knight Cancer Institute 2020-10-31
NCT01708421 Symptom Clusters in Children With Leukemia https://ClinicalTrials.gov/show/NCT01708421 Completed Duke University 2018-08-01
NCT01699217 Front-line Nilotinib Treatment of BCR-ABL+ Chronic Myeloid Leukaemia in Chronic Phase https://ClinicalTrials.gov/show/NCT01699217 Recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2019-11-30
NCT01688011 Connect® MDS/AML Disease Registry https://ClinicalTrials.gov/show/NCT01688011 Recruiting Celgene 2022-12-12
NCT01678508 Pharmacogenetically Based Dosing of Thiopurines in Childhood Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01678508 Completed Rigshospitalet, Denmark 2011-07-31
NCT01664936 Non-Invasive Cerenkov Luminescence Imaging of Lymphoma, Leukemia and Metastatic Lymph Nodes https://ClinicalTrials.gov/show/NCT01664936 Completed Memorial Sloan Kettering Cancer Center 2018-04-03
NCT01642121 Studying Biomarkers in Samples From Younger Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01642121 Completed Children’s Oncology Group 2016-05-31
NCT01642069 Studying Genes in Samples From Younger Patients With Acute Megakaryoblastic Leukemia https://ClinicalTrials.gov/show/NCT01642069 Completed Children’s Oncology Group 2016-05-31
NCT01629745 Genetic Test in Detecting Minimal Residual Disease in Samples From Younger Patients Registered on the COG-AALL08B1 Trial https://ClinicalTrials.gov/show/NCT01629745 Completed Children’s Oncology Group 2012-08-31
NCT01625143 Studying Genes in Samples From Younger Patients With Relapsed Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01625143 Completed Children’s Oncology Group 2016-05-31
NCT01626183 Studying RNA in Samples From Younger Patients With T-Cell Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01626183 Completed Children’s Oncology Group 2016-05-31
NCT01609023 A Study of Rituximab (MabThera) in Combination With Chemotherapy in Participants With CD20-Positive B-Cell Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT01609023 Completed Hoffmann-La Roche 2015-11-30
NCT01608152 Development of a Video Game for the Improvement of Outcomes in Stem Cell Transplant Survivors https://ClinicalTrials.gov/show/NCT01608152 Active, not recruiting M.D. Anderson Cancer Center 2021-12-31
NCT01595295 Registry on Hypomethylating Agents in Myeloid Neoplasms https://ClinicalTrials.gov/show/NCT01595295 Recruiting Arbeitsgemeinschaft medikamentoese Tumortherapie 2020-06-30
NCT01581528 Studying Samples From Patients With T-Cell Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01581528 Completed Children’s Oncology Group 2016-05-31
NCT01576185 Developing and Treating a Mouse Model of Acute Myeloid Leukemia Using Tissue Samples From Younger Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01576185 Completed Children’s Oncology Group 2016-05-31
NCT01575535 S0106B Studying Bone Marrow Samples From Women With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01575535 Completed Southwest Oncology Group 2012-05-31
NCT01565447 Acute Lymphoblastic Leukemia (ALL) and Lymphoblastic Lymphoma Gait Parameters Study https://ClinicalTrials.gov/show/NCT01565447 Active, not recruiting Oregon Health and Science University 2020-12-31
NCT01556386 Pharmacogenetic Analysis of Korean Pediatric Patients With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01556386 Completed Seoul National University Hospital 2012-03-31
NCT01553162 Studying Dexamethasone and Prednisone Sensitivity in Samples From Younger Patients With High-Risk B-Cell Precursor Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01553162 Completed Children’s Oncology Group 2016-05-31
NCT01540812 Treatment of Acute Lymphoblastic Leukemia HIGH RISK BCR / ABL NEGATIVE IN ADULTS https://ClinicalTrials.gov/show/NCT01540812 Completed PETHEMA Foundation 2019-11-20
NCT01540578 Studying Biomarkers as a Diagnostic Tool in Samples From Younger Patients With B-Cell Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01540578 Completed Children’s Oncology Group 2016-05-31
NCT01537159 MRI Assessment of Leukemia Response to Therapy https://ClinicalTrials.gov/show/NCT01537159 Completed OHSU Knight Cancer Institute 2018-12-31
NCT00806325 Clinical Factors Associated With the Development of Severe Sepsis in Patients Being Treated for Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00806325 Completed Ohio State University 2010-02-28
NCT01533168 Genetic Test To Identify Previously Undetectable Minimal Residual Disease in Cell Samples From Younger Patients With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01533168 Completed Children’s Oncology Group 2016-05-31
NCT01520246 Gene Expression in Samples From Patients With T-Cell Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01520246 Completed Children’s Oncology Group 2016-07-31
NCT01511575 Studying Biomarker Expression in Samples From Patients With Down Syndrome and Acute Myeloid Leukemia or Other Transient Myeloproliferative Disorder https://ClinicalTrials.gov/show/NCT01511575 Completed Children’s Oncology Group 2016-05-31
NCT01507441 Studying DNA in Samples From Younger Patients With Down Syndrome and Acute Myeloid Leukemia Treated on COG-AAML0431 Clinical Trial https://ClinicalTrials.gov/show/NCT01507441 Completed Children’s Oncology Group 2016-05-31
NCT01505699 Biomarkers in Samples From Patients With B-Cell Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01505699 Completed Eastern Cooperative Oncology Group 2012-02-06
NCT01503541 S9031-9333-0106-0112-A Study of Biomarkers in Samples From Patients With Acute Myeloid Leukemia Treated With Standard Chemotherapy With or Without Gemtuzumab Ozogamicin https://ClinicalTrials.gov/show/NCT01503541 Completed Southwest Oncology Group 2012-06-30
NCT01500499 Role of Biomarkers in Disease Progression in Samples From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01500499 Completed Children’s Oncology Group 2016-05-31
NCT01498302 Comparison of Laboratory Test Results of Minimal-Residual Disease in Samples From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01498302 Completed Children’s Oncology Group 2016-07-31
NCT03262974 Effect of Pharmacogenetics on Imatinib Plasma Level and Response https://ClinicalTrials.gov/show/NCT03262974 Active, not recruiting Assiut University 2021-05-31
NCT01490853 Follow-up of Ph+ Chronic Myleoid Leukemia Patients in Complete Cytogenetic Response With Interferon Based Therapy https://ClinicalTrials.gov/show/NCT01490853 Completed Università degli Studi di Brescia 2012-01-31
NCT01488162 An Observational Study of MabThera/Rituxan (Rituximab) in Patients With Relapsing or Refractory Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT01488162 Completed Hoffmann-La Roche 2016-10-24
NCT01475110 Observational Study in Adults With Imatinib-resistant/Intolerant Chronic Myeloid Leukemia Treated With Nilotinib https://ClinicalTrials.gov/show/NCT01475110 Recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2018-12-31
NCT01472107 Study on Number and Outcome of Pregnancy in Acute Promielocitic Leukaemia (APL) Patients Treated With Chemotherapy https://ClinicalTrials.gov/show/NCT01472107 Recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2018-12-31
NCT01470924 Acute Lymphoblastic Leukemia Relapse in Sweden 2003-2007 https://ClinicalTrials.gov/show/NCT01470924 Completed Region Örebro County NA
NCT01464047 Korean Post-marketing Surveillance for Sprycel® https://ClinicalTrials.gov/show/NCT01464047 Completed Bristol-Myers Squibb 2015-08-31
NCT01460238 Lipoprotein Lipase Expression in Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT01460238 Completed Dartmouth-Hitchcock Medical Center 2018-05-31
NCT01453062 Phase IV Observational Study in Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT01453062 Completed GlaxoSmithKline 2012-11-30
NCT01439217 Endothelial Function, Arterial Stiffness and Components https://ClinicalTrials.gov/show/NCT01439217 Completed Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 2013-02-28
NCT01438138 Study to Predict Risk of Relapse in Bone Marrow Cell Samples From Younger Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01438138 Completed Children’s Oncology Group 2016-05-31
NCT01434329 S8600-S9031-S9333-A, Study of DNA in Samples From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01434329 Completed Southwest Oncology Group 2015-12-31
NCT01421875 Biomarker Study of Chemotherapy Resistance and Outcomes in Samples From Older Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01421875 Completed Eastern Cooperative Oncology Group 2011-10-17
NCT01419496 Study of Proteins in Promoting Chemotherapy Resistance in Samples From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01419496 Completed Children’s Oncology Group 2016-05-31
NCT01407757 Study of Gemtuzumab Ozogamicin Therapy in DNA Samples From Patients With Acute Myeloid Leukemia Treated on COG-AAML0531 https://ClinicalTrials.gov/show/NCT01407757 Completed Children’s Oncology Group 2016-05-31
NCT01395628 Cell Samples From Patients With Leukemia https://ClinicalTrials.gov/show/NCT01395628 Completed Children’s Oncology Group 2016-05-31
NCT01395615 An Observational Study on The Health Related Quality of Life in Patients With Chronic Lymphocytic Leukaemia https://ClinicalTrials.gov/show/NCT01395615 Completed Hoffmann-La Roche 2009-10-31
NCT01394666 Non-interventional Treatment Patterns Study in Chronic Phase Chronic Myelogenous Leukemia (CP-CML) https://ClinicalTrials.gov/show/NCT01394666 Completed Bristol-Myers Squibb 2012-12-31
NCT01385787 MRD Testing Before and After Hematopoietic Cell Transplantation for Pediatric Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01385787 Completed Center for International Blood and Marrow Transplant Research 2017-05-31
NCT01385150 Biomarkers in Blood Samples From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01385150 Completed Eastern Cooperative Oncology Group 2012-02-03
NCT01380587 Utility of XCL1 as a Prognostic Marker in Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01380587 Completed Hospital Universitario Dr. Jose E. Gonzalez 2012-09-30
NCT01365975 Follow-up Study of Late Effects of Periconceptional Folic Acid in Mothers and Offspring in the Community Intervention Program Population: The Chinese Children and Families Study https://ClinicalTrials.gov/show/NCT01365975 Completed National Institutes of Health Clinical Center (CC) 2012-12-31
NCT01360125 S0106A, Biomarkers in Samples From Patients With Newly Diagnosed Acute Myeloid Leukemia Treated With Cytarabine-Based Chemotherapy https://ClinicalTrials.gov/show/NCT01360125 Completed Southwest Oncology Group 2015-12-31
NCT01338974 S9031-S9333-S0112-S0301-A Biomarkers Associated With Response to Cytarabine in Samples From Older Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01338974 Completed Southwest Oncology Group 2012-08-31
NCT01321385 Biomarkers in Predicting Response to Treatment in Bone Marrow Samples From Young Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01321385 Completed Children’s Oncology Group 2016-05-31
NCT04446741 Molecular Diagnostic Platform for AML https://ClinicalTrials.gov/show/NCT04446741 Recruiting PETHEMA Foundation 2022-10-31
NCT04380441 Quality of Life Model for Older Patients With AML https://ClinicalTrials.gov/show/NCT04380441 Recruiting H. Lee Moffitt Cancer Center and Research Institute 2022-05-31
NCT04369287 Prevalence and Clinical Effect of IDH1/2 Mutations in Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT04369287 Recruiting Istituto Clinico Humanitas 2020-10-15
NCT04364451 Correlation of Polymorphisms of Lipoprotein Lipase (LpL) and Apolipoprotein E (Apo E) With Lipid Profile of Children With Acute Lymphoblastic Eukaemia During Therapy With L - Asparaginase. https://ClinicalTrials.gov/show/NCT04364451 Recruiting Aristotle University Of Thessaloniki 2022-08-31
NCT04337138 A Study Of Treatment Patterns And Clinical Outcomes In Patients Diagnosed With Acute Myeloid Leukemia Who Received Mylotarg in the Real-World https://ClinicalTrials.gov/show/NCT04337138 Active, not recruiting Pfizer 2020-07-31
NCT04322084 Continuous Ambulatory Monitoring to Predict Elevated Risk of Infection in Children With Lymphoblastic Leukemia Undergoing Induction Chemotherapy (CAMPER-ALL) https://ClinicalTrials.gov/show/NCT04322084 Recruiting St. Jude Children’s Research Hospital 2021-05-01
NCT04296214 Pharmacoeconomics in the Application of 5-azacitidine in the Treatment of Myelodysplastic Syndromes and Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT04296214 Recruiting Grupo Cooperativo de Hemopatías Malignas 2021-12-31
NCT04271215 Overweight and Obesity as Prognostic Factors for Survival in Children With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT04271215 Recruiting Coordinación de Investigación en Salud, Mexico 2020-12-31
NCT04259372 Analysis of T Cell Metabolism in Acute Myeloid Leukemia Patients https://ClinicalTrials.gov/show/NCT04259372 Completed University of Freiburg 2019-12-31
NCT04253314 A Study of the Effectiveness of Venetoclax Tablets in Adult Acute Myeloid Leukemia Participants Ineligible for Standard Induction Therapy in Russian Federation https://ClinicalTrials.gov/show/NCT04253314 Recruiting AbbVie 2023-10-17
NCT04251754 The Acute Promyelocytic Leukaemia Asian Consortium (APL-AC) Project https://ClinicalTrials.gov/show/NCT04251754 Recruiting The University of Hong Kong 2025-01-31
NCT04198415 A Study of the Safety and Efficacy of Venetoclax in Japanese Participants With Relapsed and Refractory Chronic Lymphocytic Leukemia (Including Small Lymphocytic Leukemia) https://ClinicalTrials.gov/show/NCT04198415 Recruiting AbbVie 2022-03-31
NCT04187248 The Association Between Asparaginase Enzyme Activity Levels and Toxicities in Childhood Acute Lymphoblastic Leukaemia in NOPHOALL 2008 https://ClinicalTrials.gov/show/NCT04187248 Completed Aarhus University Hospital 2016-02-28
NCT04178317 A Study of the Safety and Efficacy of Venetoclax for Participants With Chronic Lymphocytic Leukemia (CLL) Used in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT04178317 Recruiting AbbVie 2026-03-25
NCT04159779 A Study of Clinical Outcomes in Relapse/Refractory Chronic Lymphocytic Leukemia (CLL) Patients Treated With Venetoclax in Greece https://ClinicalTrials.gov/show/NCT04159779 Recruiting AbbVie 2020-11-25
NCT04158011 A Retrospective Study of Patients With Leukemia Relapse in the CNS Treated With CAR T Cells https://ClinicalTrials.gov/show/NCT04158011 Active, not recruiting Sheba Medical Center 2020-03-01
NCT04157569 CtDNA After Chemotherapy in Elderly Patients With Acute Leukemia https://ClinicalTrials.gov/show/NCT04157569 Recruiting Navy General Hospital, Beijing 2024-12-31
NCT04150471 Assess Long-term Feasibility of Reduced Dose Dasatinib in Chronic Phase Chronic Myeloid Leukemia Patients https://ClinicalTrials.gov/show/NCT04150471 Recruiting Seoul St. Mary’s Hospital 2020-12-30
NCT04104035 Leukemic Stem Cell Detection for Chronic Myeloid Leukemia Patients With Major Molecular Response https://ClinicalTrials.gov/show/NCT04104035 Recruiting Ankara University 2021-01-31
NCT04089839 A Study of Dasatinib Management Among CP-CML (Chronic Phase, Chronic Myeloid Leukemia) Participants Initiating Dasatinib in a Real Life Setting https://ClinicalTrials.gov/show/NCT04089839 Active, not recruiting Bristol-Myers Squibb 2020-10-31
NCT04055558 Lymphoproliferative Disorders During the Treatment of Childhood Acute Lymphoblastic Leukemia/Lymphoma https://ClinicalTrials.gov/show/NCT04055558 Recruiting Rabin Medical Center 2019-12-18
NCT04037189 Treatment of Leukemia and Lymphoma in Children With Ataxia Telangiectasia https://ClinicalTrials.gov/show/NCT04037189 Recruiting Rabin Medical Center 2021-07-28
NCT04028531 Understanding Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT04028531 Recruiting Dana-Farber Cancer Institute 2024-09-29
NCT04024241 Medium Dose of Cytarabine and Mitoxantrone https://ClinicalTrials.gov/show/NCT04024241 Recruiting Shenzhen People’s Hospital 2019-08-31
NCT03985826 Primary Health Care Utilisation Among Survivors of Childhood Acute Lymphoblastic Leukaemia https://ClinicalTrials.gov/show/NCT03985826 Completed University of Aarhus 2019-11-30
NCT03987958 A Study to Describe the Safety and Effectiveness of Venetoclax in Acute Myeloid Leukemia (AML) Patients (REVIVE Study) https://ClinicalTrials.gov/show/NCT03987958 Recruiting AbbVie 2023-07-01
NCT03974893 Dietary Intake, Sarcopenic Obesity, and Other Treatment-Related Outcomes in Indian Children With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT03974893 Recruiting Columbia University 2021-11-30
NCT03971565 Evaluation of the Redox Profiles of Healthy and Pathological B Cells in Patients With Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT03971565 Recruiting Assistance Publique Hopitaux De Marseille 2021-03-18
NCT03933852 Observational Study on Chronic Myeloid Leukemia Patients in Any Phase Treated With Ponatinib (Iclusig®) at Any Dose https://ClinicalTrials.gov/show/NCT03933852 Recruiting University of Jena 2022-12-31
NCT03921047 Characterization of T-cell Repertoire in Patients With Acute Myeloid Leukemia Undergoing Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT03921047 Recruiting University of Southern California 2022-02-01
NCT03918655 MIF Involvement in AML https://ClinicalTrials.gov/show/NCT03918655 Recruiting Assistance Publique - Hôpitaux de Paris 2022-10-31
NCT03911128 A Treatment Protocol for Participants 1-45 Years With Acute Lymphoblastic Leukaemia https://ClinicalTrials.gov/show/NCT03911128 Recruiting Karolinska University Hospital 2020-03-31
NCT03898128 ItaliaN Observational Study of Patients With Acute Lymphoblastic Leukemia Treated With Anti-CD22 Immunoconjugate https://ClinicalTrials.gov/show/NCT03898128 Recruiting Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori 2020-10-31
NCT03894852 SRSF2 Gene Mutation in Patients With t-MDS/AML https://ClinicalTrials.gov/show/NCT03894852 Completed Assiut University 2019-12-29
NCT03885076 Gamma Delta T Cells in AML https://ClinicalTrials.gov/show/NCT03885076 Recruiting Royal Marsden NHS Foundation Trust 2020-03-31
NCT03885830 Precision Dosing of Tyrosine Kinase Inhibitors in CML Patients https://ClinicalTrials.gov/show/NCT03885830 Active, not recruiting UNC Lineberger Comprehensive Cancer Center 2020-12-31
NCT03881826 Investigation of the Gut Microbiota in Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT03881826 Recruiting Université Catholique de Louvain 2020-05-31
NCT03873857 A Study to Assess Effectiveness of Venclexta (Venetoclax) in Patients With Relapse or Refractory Chronic Lymphocytic Leukemia in Routine Clinical Practice in Russian Federation https://ClinicalTrials.gov/show/NCT03873857 Recruiting AbbVie 2022-12-03
NCT03860376 Ex Vivo Drug Sensitivity Testing and Mutation Profiling https://ClinicalTrials.gov/show/NCT03860376 Recruiting Florida International University 2022-12-15
NCT03847727 Bendamustine and Rituximab (BR) as Induction and Maintenance in Relapsed and Refractory Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT03847727 Active, not recruiting Pirogov Russian National Research Medical University 2019-12-03
NCT03803670 Clinical Significance of Occult Central Nervous System Disease In Adult Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT03803670 Completed University of Rome Tor Vergata 2019-01-01
NCT03789981 Exploring Disease Immunogenicity and the Immunological Effects of Hypomethylating Agents in Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT03789981 Recruiting Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori 2021-12-31
NCT03756675 Haploidentical Peripheral Blood Stem Cell Transplantation for Acute Leukemia https://ClinicalTrials.gov/show/NCT03756675 Recruiting Peking University People’s Hospital 2023-11-01
NCT03755856 Long-term Outcomes for Acute Myeloid Leukemia Patients https://ClinicalTrials.gov/show/NCT03755856 Recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2021-06-30
NCT03751072 Efficacy and Toxicity of Blinatumomab in the French ATU for Adult BCP-ALL R/R, or With MRD+ (FRENCH-CYTO) https://ClinicalTrials.gov/show/NCT03751072 Recruiting Group for Research in Adult Acute Lymphoblastic Leukemia 2018-11-30
NCT03735797 Cancer Stem Cells in Acute Leukemia https://ClinicalTrials.gov/show/NCT03735797 Recruiting Sanford Health 2022-07-01
NCT03728699 Microbiota Changes in Acute Myeloid Leukemia Patients Undergoing Intensive Chemotherapy https://ClinicalTrials.gov/show/NCT03728699 Recruiting Masonic Cancer Center, University of Minnesota 2025-02-28
NCT03720561 A Study to Evaluate Ibrutinib Retention in Chronic Lymphocytic Leukemia Participants Treated in a Real World Setting https://ClinicalTrials.gov/show/NCT03720561 Active, not recruiting Janssen-Cilag S.p.A. 2021-10-31
NCT03719183 Comparison of Diagnostic Yield Among M-FISH, FISH Probe Panel and Conventional Cytogenetic Analysis in AML https://ClinicalTrials.gov/show/NCT03719183 Enrolling by invitation Assiut University 2020-12-31
NCT03709017 Iclusig PMS in CML or Ph+ALL Patients https://ClinicalTrials.gov/show/NCT03709017 Recruiting Korea Otsuka Pharmaceutical Co., Ltd. 2023-06-30
NCT03678454 Iclusig® (Ponatinib) in Clinical Practice for the Treatment of Chronic Myeloid Leukemia or Ph+ Acute Lymphoblastic Leukemia in Belgium https://ClinicalTrials.gov/show/NCT03678454 Recruiting Incyte Corporation 2022-03-31
NCT03659669 A Study to Describe the Effectiveness and Safety of Venetoclax Treatment in Chronic Lymphocytic Leukemia (CLL) Patients in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT03659669 Recruiting AbbVie 2024-10-31
NCT03659084 Study of the Outcome of Patients With Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Receiving Iron Chelation Therapy After Allogeneic Hematopoietic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT03659084 Recruiting Hospices Civils de Lyon 2018-04-30
NCT03647215 CALLS: CML and Ph+ALL Low Level Mutation Prevalence Survey https://ClinicalTrials.gov/show/NCT03647215 Recruiting Incyte Corporation 2020-06-30
NCT03624686 Production of Clinical-grade Anti-CD19 Chimeric Antigen Receptor T Cells for Refractory B-cell Malignancies https://ClinicalTrials.gov/show/NCT03624686 Recruiting National Taiwan University Hospital 2020-12-31
NCT03600558 Efficacy of FLAG Regimen for the Treatment of Patients With AML https://ClinicalTrials.gov/show/NCT03600558 Recruiting Tianjin Medical University General Hospital 2020-07-31
NCT03581045 Postural Control Under Different Cognitive Loads in Adult Survivors of Acute Lymphoblastic Leukemia and Age-Matched Healthy Individuals https://ClinicalTrials.gov/show/NCT03581045 Active, not recruiting St. Jude Children’s Research Hospital 2020-06-30
NCT03582098 Clinical Outcomes and Routine Management of Adults With Chronic Lymphocytic Leukaemia Treated With Idelalisib and Rituximab in the United Kingdom (UK) and Ireland https://ClinicalTrials.gov/show/NCT03582098 Completed Gilead Sciences 2019-03-26
NCT03568266 Pharmacogenomics of Asparaginase Induced Hepatotoxicity https://ClinicalTrials.gov/show/NCT03568266 Recruiting University of Southern California 2024-05-22
NCT03545659 Childhood Acute Lymphoblastic Leukaemia: Follow-Up https://ClinicalTrials.gov/show/NCT03545659 Recruiting University of Aarhus 2020-06-30
NCT03540654 Budget Impact Analysis of Discontinuing Tyrosin Kinase Inhibitors in Patients With Chronic Myeloid Leukemia Achieving a Complete Molecular Response by Using Probabilistic Markov Approach https://ClinicalTrials.gov/show/NCT03540654 Completed University Hospital, Bordeaux 2018-10-31
NCT03537560 Detection of IDH2 Mutations and Monitoring Molecular Residual Disease in Patients With AML https://ClinicalTrials.gov/show/NCT03537560 Enrolling by invitation Chang Gung Memorial Hospital 2019-09-30
NCT03528941 The Incidence of Hepatitis B Reactivations in Patients Affected by Chronic Lymphocytic Leukemia With Ibrutinib https://ClinicalTrials.gov/show/NCT03528941 Recruiting Gruppo Italiano Malattie EMatologiche dell’Adulto 2020-08-31
NCT03529760 Chemotherapy Efficacy and Follow-up Study of Hepatitis B Virus Infection and Reactivation in Children With Leukemia https://ClinicalTrials.gov/show/NCT03529760 Recruiting Children’s Hospital of Chongqing Medical University 2019-07-15
NCT03529227 Gazyva Infusion Reaction Investigation https://ClinicalTrials.gov/show/NCT03529227 Recruiting Healthy Future 2019-03-31
NCT03526926 A Post-Marketing Observational Study of VYXEOSâ„¢ https://ClinicalTrials.gov/show/NCT03526926 Active, not recruiting Jazz Pharmaceuticals 2020-01-31
NCT03488862 Pilot Evaluation of a Microfluidic Assay to Detect Minimal Residual Disease and Predict Relapse in AML Patients https://ClinicalTrials.gov/show/NCT03488862 Active, not recruiting UNC Lineberger Comprehensive Cancer Center 2020-10-01
NCT03481868 EPIgenetics and in Vivo Resistance of Chronic Myeloid Leukemia Stem Cells to Tyrosine Kinase Inhibitors https://ClinicalTrials.gov/show/NCT03481868 Recruiting University Hospital, Clermont-Ferrand 2021-02-10
NCT03471416 Nutritional Status in Children With ALL in Guatemala https://ClinicalTrials.gov/show/NCT03471416 Recruiting Columbia University 2021-01-31
NCT03476655 Clinical Outcomes of Chronic Lymphocytic Leukemia (CCL) and Mantle Cell Lymphoma (MCL) Participants Treated With Ibrutinib: A Medical Chart Review From India https://ClinicalTrials.gov/show/NCT03476655 Completed Johnson & Johnson Private Limited 2019-05-14
NCT03466944 PUMA (Paediatric Osseous Marrow Assessment) https://ClinicalTrials.gov/show/NCT03466944 Recruiting Institute of Cancer Research, United Kingdom 2020-12-31
NCT03454503 Effectiveness and Safety Study of Generic Imatinib in Chronic Myeloid Leukemia Patients in Egypt https://ClinicalTrials.gov/show/NCT03454503 Active, not recruiting Hikma Pharmaceuticals LLC 2021-01-31
NCT03450512 Incidence of Neutropenic Enterocolitis Study in Acute Myeloid Leukemia Patients During Intensive Therapy https://ClinicalTrials.gov/show/NCT03450512 Recruiting Centre Hospitalier Universitaire, Amiens 2022-12-01
NCT03435341 Survival in Patients Older Than 60 Years With Newly Diagnosed AML in Spain https://ClinicalTrials.gov/show/NCT03435341 Active, not recruiting Celgene 2020-02-28
NCT03433521 Observational Study of Spatio-Temporal Patterns of New Cases of Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT03433521 Completed Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz 2019-01-15
NCT03421626 Clinical Evaluation of a Test for Monitoring Patients Diagnosed With Chronic Myeloid Leukemia (CML) https://ClinicalTrials.gov/show/NCT03421626 Completed Cepheid 2018-08-20
NCT03422731 Multi-modality Imaging and Collection of Biospecimen Samples in Understanding Bone Marrow Changes in Patients With Acute Myeloid Leukemia Undergoing TBI and Chemotherapy https://ClinicalTrials.gov/show/NCT03422731 Recruiting City of Hope Medical Center 2023-02-06
NCT03413644 Evaluation of ClearLLab Leukemia and Lymphoma Panels https://ClinicalTrials.gov/show/NCT03413644 Completed Beckman Coulter, Inc. 2018-04-27
NCT01252589 Patient Reported Outcomes in Chronic Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01252589 Completed Gruppo Italiano Malattie EMatologiche dell’Adulto 2013-09-30
NCT01252485 Registry Study on Patient Characteristics, Biological Disease Profile and Clinical Outcome in Acute Myeloid Leukemia and Related Neoplasms, and Higher Risk Myelodysplastic Syndrome - The Biology and Outcome (BiO)-Project https://ClinicalTrials.gov/show/NCT01252485 Recruiting University of Ulm NA
NCT01251159 Biomarkers in Bone Marrow Samples From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01251159 Completed Eastern Cooperative Oncology Group 2009-06-15
NCT01247584 Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01247584 Completed Children’s Oncology Group 2016-05-31
NCT01245231 Prognostic Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01245231 Completed Children’s Oncology Group 2016-05-31
NCT01244750 Studying First Line Treatment of Chronic Myeloid Leukemia (CML) in a Real-world Setting https://ClinicalTrials.gov/show/NCT01244750 Active, not recruiting Bristol-Myers Squibb 2020-01-30
NCT01232855 Biomarkers in Tissue Samples From Patients With Acute Promyelocytic Leukemia https://ClinicalTrials.gov/show/NCT01232855 Completed Children’s Oncology Group 2011-02-28
NCT01232842 Biomarker Study in Tissue Samples From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01232842 Completed Children’s Oncology Group 2016-07-31
NCT03436524 A Prognostic Tool for Early Stage CLL https://ClinicalTrials.gov/show/NCT03436524 Recruiting Oncology Institute of Southern Switzerland 2020-02-28
NCT01229124 RNA Biomarkers in Tissue Samples From Infants With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01229124 Completed Children’s Oncology Group 2016-05-31
NCT01229956 Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01229956 Completed Children’s Oncology Group 2016-05-31
NCT01224093 An Observational Study on the Safety Profile of MabThera/Rituxan (Rituximab) in Combination With Chemotherapy in Patients With B Cell-lineage Chronic Lymphocytic Leukaemia (MABERYC) https://ClinicalTrials.gov/show/NCT01224093 Completed Hoffmann-La Roche 2014-02-28
NCT01215487 A Study Investigating the Predictive Value of Philadelphia Positive Stem Cell Properties in Newly Diagnosed Patients With Chronic Myeloid Leukemia in Chronic Phase Receiving Treatment With Imatinib https://ClinicalTrials.gov/show/NCT01215487 Recruiting University of British Columbia 2022-01-31
NCT01207843 Optimized Radiological Diagnosis of Hepatic Candidiasis During the Treatment of Acute Leukemias https://ClinicalTrials.gov/show/NCT01207843 Completed University of Zurich 2011-04-30
NCT01203033 Prospective Pilot Study of Bone Marrow and Peripheral Blood Samples From AML Patients to Characterize the Biologic Heterogeneity of the Disease Using Single Cell Network Profiling (SCNP) https://ClinicalTrials.gov/show/NCT01203033 Completed West Virginia University 2012-09-30
NCT01199562 Infection Prophylaxis and Management in Treating Cytomegalovirus (CMV) Infection in Patients With Hematologic Malignancies Previously Treated With Donor Stem Cell Transplant https://ClinicalTrials.gov/show/NCT01199562 Completed City of Hope Medical Center 2013-12-31
NCT01185886 Study of Blood and Tissue Samples in Children With Newly Diagnosed Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01185886 Active, not recruiting European Organisation for Research and Treatment of Cancer - EORTC 2021-06-30
NCT01178086 A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL) https://ClinicalTrials.gov/show/NCT01178086 Completed Hoffmann-La Roche 2015-06-30
NCT01174615 Collection of Blood and/or Bone Marrow for Investigation and Characterization of Normal and Abnormal Cell Growth https://ClinicalTrials.gov/show/NCT01174615 Recruiting University of Massachusetts, Worcester 2099-12-31
NCT01169363 Biomarkers in Bone Marrow and Blood Samples From Older Patients With Acute Myeloid Leukemia Treated With Cytarabine-Based Therapy https://ClinicalTrials.gov/show/NCT01169363 Completed Eastern Cooperative Oncology Group 2010-08-08
NCT01150669 Lestaurtinib With or Without Chemotherapy Agents in Samples From Young Patients With Leukemia https://ClinicalTrials.gov/show/NCT01150669 Completed Children’s Oncology Group 2016-05-31
NCT01150656 Obatoclax Mesylate in Samples From Young Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01150656 Completed Children’s Oncology Group 2016-05-31
NCT01150058 Drug Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01150058 Completed Children’s Oncology Group 2012-11-30
NCT01148927 Quality of Life Study for Adult Patients With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01148927 Completed University Health Network, Toronto 2012-06-30
NCT01146223 Biomarkers in Bone Marrow Samples From Patients With Acute Promyelocytic Leukemia https://ClinicalTrials.gov/show/NCT01146223 Completed Children’s Oncology Group 2011-06-30
NCT01146210 Identification of de Novo Fanconi Anemia in Younger Patients With Newly Diagnosed Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01146210 Completed Children’s Oncology Group 2016-05-31
NCT01145469 Biomarkers in DNA Samples From Patients With Chronic Lymphocytic Leukemia Previously Treated With Fludarabine-Based Therapy https://ClinicalTrials.gov/show/NCT01145469 Completed Eastern Cooperative Oncology Group 2010-08-01
NCT01142427 Risk-Based Classification System of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01142427 Active, not recruiting Children’s Oncology Group 2015-05-01
NCT01144793 Biomarker To Evaluate Protein Profiles of Neutropenic Fever/Infection With Acute or Chronic Leukemias https://ClinicalTrials.gov/show/NCT01144793 Completed Stanford University 2008-06-30
NCT01139931 Biomarker Changes in Samples From Young Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01139931 Completed Children’s Oncology Group 2016-05-31
NCT01139333 Blood and Tumor Tissue Samples From Young Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01139333 Completed Children’s Oncology Group 2016-05-31
NCT01138332 Biomarkers in Young Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01138332 Completed Children’s Oncology Group 2010-03-31
NCT01138319 Biomarkers in Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01138319 Completed Children’s Oncology Group 2010-03-31
NCT01139320 Biomarkers in DNA Samples From Younger Patients With Newly Diagnosed Acute Myeloid Leukemia Receiving Gemtuzumab Ozogamicin https://ClinicalTrials.gov/show/NCT01139320 Completed Children’s Oncology Group 2016-05-31
NCT01139307 Biomarkers in Samples From Patients With Down Syndrome and Acute Megakaryoblastic Leukemia https://ClinicalTrials.gov/show/NCT01139307 Completed Children’s Oncology Group 2012-08-31
NCT01138306 Biomarkers in Samples From Young Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01138306 Completed Children’s Oncology Group 2016-05-31
NCT01137825 Registry of Older Patients With Cancer https://ClinicalTrials.gov/show/NCT01137825 Active, not recruiting UNC Lineberger Comprehensive Cancer Center 2030-06-30
NCT01137643 Tissue, Blood, and Body Fluid Sample Collection From Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT01137643 Active, not recruiting UNC Lineberger Comprehensive Cancer Center 2040-07-31
NCT01119586 Biomarkers in DNA Samples From Patients With High-Risk Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01119586 Completed Children’s Oncology Group 2015-12-31
NCT01117142 A Study of the Kinetics of Lymphoid Cells in Patients With Monoclonal B-cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL), Mantle Cell Lymphoma (MCL) and Healthy Volunteers https://ClinicalTrials.gov/show/NCT01117142 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT01110850 Direct Measurement of Leukemic Cell Turnover (Synthesis and Removal) in Patients With Chronic Lymphocytic Leukemia (CLL) Using Deuterated Water https://ClinicalTrials.gov/show/NCT01110850 Completed Northwell Health 2018-05-31
NCT01094392 Hemostasis During Asparaginase Treatment in Acute Lymphoblastic Leukemia(ALL) https://ClinicalTrials.gov/show/NCT01094392 Recruiting Aarhus University Hospital 2019-12-31
NCT01081015 Connectâ„¢ CLL: The Chronic Lymphocytic Leukemia Disease Registry https://ClinicalTrials.gov/show/NCT01081015 Completed Celgene 2017-12-31
NCT01059734 S9031-S9126-S9333-S9500-B Biomarker Expression in Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01059734 Completed Southwest Oncology Group 2012-06-30
NCT01057290 Studying Biomarkers in Cell Samples From Young Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01057290 Completed Children’s Oncology Group 2016-05-31
NCT01057199 Studying Biomarkers in Cell Samples From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01057199 Completed Children’s Oncology Group 2010-06-30
NCT01057095 Studying Gene Expression in Tissue Samples From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01057095 Completed Children’s Oncology Group 2010-04-30
NCT01047020 Motor Proficiency And Physical Activity in Adult Survivors of Childhood Acute Lymphoblastic Leukemia (ALL) https://ClinicalTrials.gov/show/NCT01047020 Completed St. Jude Children’s Research Hospital 2013-04-30
NCT01046305 Symptom Burden in Chronic Myeloid Leukemia (CML) https://ClinicalTrials.gov/show/NCT01046305 Active, not recruiting M.D. Anderson Cancer Center 2020-11-30
NCT01035307 Studying Biomarkers in Tissue Samples From Young Patients With Acute Myeloid Leukemia Previously Enrolled on Clinical Trial POG-9421 https://ClinicalTrials.gov/show/NCT01035307 Completed Children’s Oncology Group 2016-05-31
NCT01030913 B-type Chronic Lymphocytic Leukemia (B-CLL) Subgroups: Maturation Stage and Gene Expression https://ClinicalTrials.gov/show/NCT01030913 Recruiting Northwell Health 2021-01-31
NCT01034839 High-dose Cytarabine and Survival in AML https://ClinicalTrials.gov/show/NCT01034839 Completed University of Sao Paulo General Hospital 2008-12-31
NCT01028430 B Cell Repertoires in Chronic Lymphocytic Leukemia and Aging https://ClinicalTrials.gov/show/NCT01028430 Recruiting Northwell Health 2021-01-31
NCT01024127 Studying DNA in Blood and Bone Marrow Samples From Younger Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01024127 Completed Children’s Oncology Group 2016-05-31
NCT01016379 Studying DNA in Blood and Bone Marrow Samples From Young Patients With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT01016379 Completed Children’s Oncology Group 2016-05-31
NCT01014195 Risk of Psychopathology and Neurocognitive Impairment in Leukemia Survivors https://ClinicalTrials.gov/show/NCT01014195 Completed St. Jude Children’s Research Hospital 2014-10-31
NCT01005368 Study of Biomarkers in Blood and Bone Marrow Samples From Patients With Previously Untreated Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT01005368 Active, not recruiting Alliance for Clinical Trials in Oncology 2100-01-31
NCT01005277 Study of Biomarkers in DNA Samples From Patients With Acute Lymphoblastic Leukemia or Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01005277 Active, not recruiting Children’s Oncology Group 2100-01-31
NCT01004965 Study of Bone Marrow and Blood Samples in Patients With Untreated Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia Enrolled on Clinical Trial CALGB-9621 or CALGB-9720 https://ClinicalTrials.gov/show/NCT01004965 Active, not recruiting Alliance for Clinical Trials in Oncology 2011-01-31
NCT01004640 Study of Blood and Bone Marrow Samples in Patients With Chronic Myelogenous Leukemia Enrolled on a CALGB Clinical Trial https://ClinicalTrials.gov/show/NCT01004640 Active, not recruiting Alliance for Clinical Trials in Oncology 2001-02-28
NCT00996047 S9007, Study of Bone Marrow and Blood Samples From Patients With Leukemia or Other Hematopoietic Cancers https://ClinicalTrials.gov/show/NCT00996047 Completed Southwest Oncology Group 2012-01-31
NCT00993694 Methemoglobinemia in Young Patients With Hematologic Cancer or Aplastic Anemia Treated With Dapsone https://ClinicalTrials.gov/show/NCT00993694 Completed Vanderbilt University Medical Center 2009-12-31
NCT00993135 Kidney Dysfunction in Children and Young Adults Who Have Received Methotrexate for Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT00993135 Completed Vanderbilt University Medical Center 2009-12-31
NCT00969891 Study of Dosage Individualisation for the Treatment of Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00969891 Completed University of Copenhagen NA
NCT00964821 Flu Vaccine in Preventing Influenza Infection in Healthy Volunteers and in Patients Who Have Undergone Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00964821 Completed City of Hope Medical Center 2013-05-31
NCT00956475 Quality of Life in Younger Leukemia and Lymphoma Survivors https://ClinicalTrials.gov/show/NCT00956475 Completed Case Comprehensive Cancer Center 2010-09-30
NCT00954720 Observational Study of Iron Overload in Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT00954720 Completed Dana-Farber Cancer Institute 2011-01-31
NCT00947830 Investigating Intracellular and Plasma Imatinib Levels in Chronic Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00947830 Completed McMaster University 2012-04-30
NCT00920842 Study of Metabolic Syndrome in Adolescent and Young Adult Survivors of Childhood Leukemia Who Have Undergone Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00920842 Completed Fred Hutchinson Cancer Research Center 2011-07-31
NCT00920738 Metabolic Syndrome in Childhood Cancer Survivors https://ClinicalTrials.gov/show/NCT00920738 Completed University of Minnesota 2010-07-31
NCT00919425 S9910, Collecting and Storing Blood and Bone Marrow Samples From Patients With Hematologic Cancer https://ClinicalTrials.gov/show/NCT00919425 Completed Southwest Oncology Group 2012-01-31
NCT00923507 Natural History Study of Monoclonal B Cell Lymphocytosis (MBL), Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma (CLL/SLL), Lymphoplasmacytic Lymphoma (LPL)/Waldenstrom Macroglobulinemia (WM), and Splenic Marginal Zone Lymphoma (SMZL) https://ClinicalTrials.gov/show/NCT00923507 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT00900224 Studying Tissue and Blood Samples From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00900224 Active, not recruiting Alliance for Clinical Trials in Oncology 2015-12-31
NCT00900380 Studying Tissue Samples to Learn More About Drug Resistance in Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00900380 Completed Eastern Cooperative Oncology Group 2013-12-30
NCT00899899 Resistance to Methotrexate in Patients With Acute Lymphoblastic Leukemia in Relapse or Remission https://ClinicalTrials.gov/show/NCT00899899 Completed Children’s Oncology Group 2005-03-31
NCT00899873 Biomarkers in Samples From Patients With Chronic Lymphocytic Leukemia Treated on Clinical Trial ECOG-2997 https://ClinicalTrials.gov/show/NCT00899873 Completed Eastern Cooperative Oncology Group 2012-07-17
NCT00899223 Collecting and Storing Blood, Bone Marrow, and Other Samples From Patients With Acute Leukemia, Chronic Leukemia, or Myelodysplastic Syndromes https://ClinicalTrials.gov/show/NCT00899223 Active, not recruiting Alliance for Clinical Trials in Oncology 2020-12-31
NCT00899795 Evaluating Cell Damage in Patients With Acute Myeloid Leukemia, Myelodysplastic Syndromes, or Fanconi Anemia; in Patients Who Were Exposed to Alkylating Agents; and in Healthy Volunteers https://ClinicalTrials.gov/show/NCT00899795 Completed OHSU Knight Cancer Institute 2010-10-31
NCT00898469 Identifying Risk Factors for Bone Tissue Death in Young Patients With Acute Lymphoblastic Leukemia Treated on Clinical Trial CCG-1882 https://ClinicalTrials.gov/show/NCT00898469 Completed Children’s Oncology Group 2016-05-31
NCT00899743 S9333A Study of Blood and Bone Marrow Samples From Patients With Previously Untreated Primary Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00899743 Completed Southwest Oncology Group 2009-06-30
NCT00899652 DNA Analysis of Bone Marrow and Blood Samples From Young Patients With Acute Myeloid Leukemia or Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT00899652 Completed Children’s Oncology Group 2005-09-30
NCT00899171 S9031-S9126-S9333-S9500-A, Studying Bone Marrow and Blood Samples From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00899171 Completed Southwest Oncology Group 2012-09-30
NCT00899015 Assessing Arsenic Trioxide in Young Patients With Leukemia or Lymphoma Who Were Treated on Clinical Trial NCI-00-C-0070J https://ClinicalTrials.gov/show/NCT00899015 Completed National Institutes of Health Clinical Center (CC) NA
NCT00898755 Collecting and Storing Tissue From Young Patients With Cancer https://ClinicalTrials.gov/show/NCT00898755 Completed Children’s Oncology Group 2008-07-17
NCT00899366 DNA Analysis of Tissue From Patients With T-Cell Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT00899366 Completed Eastern Cooperative Oncology Group 2009-07-30
NCT00898261 Gene Expression in Tissue From Patients With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT00898261 Completed Eastern Cooperative Oncology Group 2012-07-19
NCT00898456 Multidrug Resistance Genes in Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00898456 Active, not recruiting Alliance for Clinical Trials in Oncology 2100-01-31
NCT00898092 Genetics Study of Tissue Collected From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00898092 Active, not recruiting Alliance for Clinical Trials in Oncology 2012-12-31
NCT00898079 Collecting and Storing Malignant, Borderline Malignant Neoplasms, and Related Samples From Young Patients With Cancer https://ClinicalTrials.gov/show/NCT00898079 Completed Children’s Oncology Group 2018-06-30
NCT00897936 DNA Analysis of Tumor Tissue From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00897936 Completed Eastern Cooperative Oncology Group 2006-04-23
NCT00897559 Study of Bone Marrow Samples From Patients With Acute Leukemia https://ClinicalTrials.gov/show/NCT00897559 Completed Eastern Cooperative Oncology Group 2009-11-11
NCT00897325 Collecting and Storing Samples of Bone Marrow and Blood From Patients With Relapsed Acute Lymphoblastic Leukemia or Non-Hodgkin Lymphoma https://ClinicalTrials.gov/show/NCT00897325 Completed Children’s Oncology Group 2019-12-31
NCT00897078 Study of Metabolic Syndrome in Young Patients Who Are Acute Lymphoblastic Leukemia Survivors and Their Healthy Siblings https://ClinicalTrials.gov/show/NCT00897078 Completed Vanderbilt University 2011-10-31
NCT00896766 Laboratory Study of Lymphoblasts in Young Patients With High-Risk Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT00896766 Completed Children’s Oncology Group 2016-05-31
NCT00896701 Relationship Between Natural Killer Cells’ Ability to Kill Leukemia Cells and the Outcome of Patients With Acute Myeloid Leukemia Previously Treated With Interleukin-2 https://ClinicalTrials.gov/show/NCT00896701 Completed Alliance for Clinical Trials in Oncology 2014-04-30
NCT00898404 Response or Resistance to Chemotherapy in Young Patients With Acute Lymphoblastic Leukemia Treated With Methotrexate https://ClinicalTrials.gov/show/NCT00898404 Completed Children’s Oncology Group 2016-05-31
NCT00896129 Mid-to Long-Term Outcomes in Chronic Myeloid Leukemia (CML) Patients With Complete Cytogenetic Response After Imatinib as First Line Therapy https://ClinicalTrials.gov/show/NCT00896129 Completed Gruppo Italiano Malattie EMatologiche dell’Adulto 2010-12-31
NCT00890435 Decision Making About Participating in Pharmacokinetic Studies in Patients Enrolled in a Phase I Treatment Clinical Trial https://ClinicalTrials.gov/show/NCT00890435 Completed Children’s Oncology Group 2009-08-31
NCT00889031 Protocol to Obtain Blood Samples for Leukemia Research https://ClinicalTrials.gov/show/NCT00889031 Completed Dartmouth-Hitchcock Medical Center 2018-03-09
NCT00866671 Observational Study of Nelarabine in Children and Young Adults https://ClinicalTrials.gov/show/NCT00866671 Completed GlaxoSmithKline 2014-09-30
NCT00897182 Identifying Cancer Genes in in Blood and Bone Marrow Samples From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00897182 Completed Alliance for Clinical Trials in Oncology 2014-03-31
NCT04070807 Italian Observational Study of Patients With Acute Myeloid Leukemia Treated With Small Molecule Inhibiting BCL-2 https://ClinicalTrials.gov/show/NCT04070807 Recruiting Istituto Scientifico Romagnolo per lo Studio e la cura dei Tumori 2020-12-31
NCT03047083 Treatment Patterns and Key Healthcare Resource Use in Acute Myeloid Leukemia (AML) With or Without FMS-like Tyrosine Kinase-3 (FLT3) Mutation Study Based on Retrospective Chart Review https://ClinicalTrials.gov/show/NCT03047083 Completed Astellas Pharma Inc 2017-05-19
NCT03294980 Chronic Lymphoid Leukaemia Observatory in Finistere Area, France https://ClinicalTrials.gov/show/NCT03294980 Recruiting University Hospital, Brest 2025-11-30
NCT01362985 Analysis of Data Collected in the European Group for Blood and Marrow Transplantation (EBMT) Registry for Off-Label Transplant Use of Plerixafor https://ClinicalTrials.gov/show/NCT01362985 Completed Sanofi 2014-07-31
NCT03633045 Observational Study of Ibrutinib Use in CLL https://ClinicalTrials.gov/show/NCT03633045 Recruiting Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health 2021-09-30
NCT03350152 Treatment With Low-Dose Cytarabine in Elderly Patients (Age 70 Years or Older) With Acute Myeloid Leukemia: A Single Institution Experience. https://ClinicalTrials.gov/show/NCT03350152 Completed Hospices Civils de Lyon 2014-06-01
NCT02344966 Cohort Study of New Prognostic Factors With Peripheral Blood and Bone Marrow Evaluation at the Time of Diagnosis and During Treatment or Thereafter in Acute Leukemia https://ClinicalTrials.gov/show/NCT02344966 Recruiting Yonsei University 2021-02-28
NCT00816114 Chart Review Study of Chronic Myelogenous Leukemia (CML) Patients Treated With Imatinib Outside of a Clinical Trial https://ClinicalTrials.gov/show/NCT00816114 Recruiting M.D. Anderson Cancer Center 2020-06-30
NCT01519648 A Russian Prospective Observational Study of Invasive Fungal Infections in Patients With Acute Leukemia and Hematopoietic Stem Cell Transplantation https://ClinicalTrials.gov/show/NCT01519648 Completed National Hematological Society, Russia 2013-09-30
NCT01437202 Pharmacogenomics Validation for Imatinib in Chronic Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01437202 Completed Asan Medical Center 2012-09-30
NCT00801346 Metabolic Syndrome in Young Patients With Acute Lymphoblastic Leukemia in Remission https://ClinicalTrials.gov/show/NCT00801346 Completed Vanderbilt University Medical Center 2016-04-30
NCT04437420 Preclinical Project on the Traitment of Acute Lymphoblastique Leukemia With NVP-BEP800, an Inhibitor of the Heat Shock Protein HSP90 https://ClinicalTrials.gov/show/NCT04437420 Recruiting Centre Hospitalier Universitaire Dijon 2021-09-30
NCT03425591 A Study of Ibrutinib in the Treatment of Chronic Lymphocytic Leukemia and Mantle-cell Lymphoma in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT03425591 Recruiting Janssen-Cilag Ltd. 2022-05-22
NCT03165851 Efficacy Analysis of Comparison of CAMS(Chinese Academy of Medical Sciences)-2005 Trial and CAMS-2009 Trial for Pediatric Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT03165851 Completed Institute of Hematology & Blood Diseases Hospital 2012-12-31
NCT02915224 A Study of Obinutuzumab Evaluating Efficacy, Safety and Cost of Disease Management in Participants With Chronic Lymphocytic Leukemia and Comorbidities https://ClinicalTrials.gov/show/NCT02915224 Active, not recruiting Hoffmann-La Roche 2020-04-30
NCT02856204 Shotgun Sequencing in Diagnosing Febrile Neutropenia in Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT02856204 Completed Stanford University 2017-12-31
NCT02733445 Metabolic Outcomes in Patients Receiving Tyrosine Kinase Inhibitor (TKI) Therapy With Dasatinib or Nilotinib https://ClinicalTrials.gov/show/NCT02733445 Completed Bristol-Myers Squibb 2015-12-31
NCT02581917 Metabolic Changes in Blood Samples From Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT02581917 Recruiting Wake Forest University Health Sciences 2020-09-30
NCT01087333 Collection of Human Samples to Study Hairy Cell and Other Leukemias, and to Develop Recombinant Immunotoxins for Cancer Treatment https://ClinicalTrials.gov/show/NCT01087333 Recruiting National Institutes of Health Clinical Center (CC) NA
NCT02188290 Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation https://ClinicalTrials.gov/show/NCT02188290 Completed Kiadis Pharma 2015-06-30
NCT03595969 Association Between Mitochondrial DNA Content and Risk of Acute Leukemia https://ClinicalTrials.gov/show/NCT03595969 Completed Fourth Military Medical University 2019-10-01
NCT03415035 Study Venetoclax Effectiveness and Real‐Life Treatment Management in Participants With Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT03415035 Recruiting AbbVie 2022-03-30
NCT03526666 Ascorbic Acid Levels in MDS, AML, and CMML Patients https://ClinicalTrials.gov/show/NCT03526666 Completed Van Andel Research Institute 2018-10-31
NCT01076569 Biomarkers in Bone Marrow Samples From Pediatric Patients With High-Risk Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01076569 Completed Children’s Oncology Group 2016-05-31
NCT00897507 DNA Analysis of Tumor Tissue Samples From Young Patients With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT00897507 Active, not recruiting Children’s Oncology Group 2100-01-31
NCT00664131 Neurologic Morbidity and Disability in Acute Lymphoblastic Leukemia Survivors https://ClinicalTrials.gov/show/NCT00664131 Completed St. Jude Children’s Research Hospital 2008-10-31
NCT00632255 Long Term Therapy With Imatinib: Development of Late Side Effects and Compliance to Treatment https://ClinicalTrials.gov/show/NCT00632255 Completed Imperial College London 2009-05-31
NCT00606216 Structural Imaging and Cognitive Functions in Adult Stem Cell Transplant Recipients Treated With Chemotherapy Alone or in Combination With Radiotherapy https://ClinicalTrials.gov/show/NCT00606216 Completed Memorial Sloan Kettering Cancer Center 2015-12-31
NCT00569842 Investigation of the Cylex® ImmuKnow® Assay https://ClinicalTrials.gov/show/NCT00569842 Completed Indiana University 2010-02-28
NCT00552825 Pulmonary Function at Presentation and Follow-up in Hemato-Oncology 3-7 Years Old Children https://ClinicalTrials.gov/show/NCT00552825 Completed Sheba Medical Center NA
NCT00525746 Molecular Epidemiology of Therapy-related Acute Myeloid Leukemia/Myelodysplastic Syndrome (AML/MDS) https://ClinicalTrials.gov/show/NCT00525746 Active, not recruiting M.D. Anderson Cancer Center 2025-03-31
NCT00513175 Non-Myeloablative Allogeneic Stem Cell Transplantation With Matched Unrelated Donors for Treatment of Hematologic Malignancies, Renal Cell Carcinoma, and Aplastic Anemia https://ClinicalTrials.gov/show/NCT00513175 Completed University of California, San Francisco NA
NCT00510315 Abdominal Obesity and Cardiovascular Risk Factors in Women Who Survived Cancer or a Related Illness Following Total Body Irradiation and Stem Cell Transplant https://ClinicalTrials.gov/show/NCT00510315 Active, not recruiting Memorial Sloan Kettering Cancer Center 2021-01-31
NCT00504920 Symptom-Related Cytokines in Acute Myeloblastic Leukemia and Myelodysplastic Syndrome Patients https://ClinicalTrials.gov/show/NCT00504920 Completed M.D. Anderson Cancer Center 2008-09-30
NCT00503256 Genetic Study of Chronic Lymphocytic Leukemia Families https://ClinicalTrials.gov/show/NCT00503256 Active, not recruiting M.D. Anderson Cancer Center 2019-09-30
NCT00502983 Molecular Epidemiology of Acute Myelogenous Leukemia https://ClinicalTrials.gov/show/NCT00502983 Active, not recruiting M.D. Anderson Cancer Center 2020-09-30
NCT00505141 Urban Environmental Exposures and Childhood Cancer https://ClinicalTrials.gov/show/NCT00505141 Completed Georgetown University NA
NCT00499785 Physical and Mental Assessment of Older Patients With Newly Diagnosed Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00499785 Completed Wake Forest University Health Sciences 2009-01-31
NCT00489632 Children’s Resiliency, Adjustment, and Coping https://ClinicalTrials.gov/show/NCT00489632 Completed M.D. Anderson Cancer Center 2011-01-31
NCT00481858 Kinetic Biomarker for Chronic Lymphocytic Leukemia Prognosis https://ClinicalTrials.gov/show/NCT00481858 Completed KineMed 2010-07-31
NCT00482352 Risk-Group Classification of Patients With Newly Diagnosed Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT00482352 Completed Children’s Oncology Group 2012-04-30
NCT00459524 Quality of Life of Patients With Acute Myelogenous Leukemia (AML) or Myelodysplastic Syndrome (MDS) https://ClinicalTrials.gov/show/NCT00459524 Completed M.D. Anderson Cancer Center 2009-03-31
NCT00437060 Brain Function in Young Patients Receiving Methotrexate for Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT00437060 Completed Children’s Oncology Group 2015-09-30
NCT00429910 Natural History Study of Patients With Chronic Myelogenous Leukemia https://ClinicalTrials.gov/show/NCT00429910 Completed Dana-Farber Cancer Institute 2005-09-30
NCT01072240 An Observational Study on Infusion-related Adverse Events at Administration of MabThera (Rituximab) in Patients With Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT01072240 Completed Hoffmann-La Roche 2011-06-30
NCT01057303 Studying Gene Expression in Tissue Samples From Young Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT01057303 Completed Children’s Oncology Group 2010-06-30
NCT00390715 Treatment of Acute Myeloblastic Leukemia in Younger Patients https://ClinicalTrials.gov/show/NCT00390715 Completed PETHEMA Foundation 2007-12-31
NCT00344825 Vitalis Study - Observational Study on the Quality of Life in Patients Under Treatment for B-Chronic Lymphocytic Leukemia (B-CLL) https://ClinicalTrials.gov/show/NCT00344825 Completed Sanofi 2006-11-30
NCT00341016 Scientific Protocol for the Study of Leukemia and Other Hematologic Diseases Among Clean-up Workers in Ukraine Following the Chernobyl Accident https://ClinicalTrials.gov/show/NCT00341016 Completed National Institutes of Health Clinical Center (CC) 2020-02-12
NCT00339963 Genome Expression in Lymphoma, Leukemia and Multiple Myeloma https://ClinicalTrials.gov/show/NCT00339963 Completed National Institutes of Health Clinical Center (CC) NA
NCT00339664 Analyses of Human Samples Collected in Clinical Trials https://ClinicalTrials.gov/show/NCT00339664 Completed National Institutes of Health Clinical Center (CC) 2020-03-17
NCT00330538 Osteoporosis in Children With ALL https://ClinicalTrials.gov/show/NCT00330538 Completed Children’s Mercy Hospital Kansas City NA
NCT00286845 Use of the MiCK Assay for Apoptosis in AML https://ClinicalTrials.gov/show/NCT00286845 Completed Pierian Biosciences NA
NCT00281814 Caregiver Support in the Coping of Patients Who Are Undergoing a Donor Bone Marrow Transplant https://ClinicalTrials.gov/show/NCT00281814 Completed The Cleveland Clinic 2008-12-31
NCT00277056 Dysregulated Tyrosine Kinase Signaling in Leukemia https://ClinicalTrials.gov/show/NCT00277056 Completed University of New Mexico 2005-10-31
NCT00281801 Caregiver Support in the Quality of Life of Patients Who Are Undergoing Donor Bone Marrow Transplantation https://ClinicalTrials.gov/show/NCT00281801 Completed Case Comprehensive Cancer Center 2008-12-31
NCT00257647 Use of SV40 Vectors to Treat Chronic Myeloid Leukemia (CML) https://ClinicalTrials.gov/show/NCT00257647 Completed Hadassah Medical Organization NA
NCT00179868 C-Reactive Protein as a Predictor of Stem Cell Transplant Complications https://ClinicalTrials.gov/show/NCT00179868 Completed Ann & Robert H Lurie Children’s Hospital of Chicago 2008-02-29
NCT00126477 Quality of Life of Adult Cancer Survivors Who Have Undergone a Previous Bone Marrow or Peripheral Stem Cell Transplant for a Childhood Hematologic Cancer https://ClinicalTrials.gov/show/NCT00126477 Completed Fred Hutchinson Cancer Research Center 2007-04-30
NCT00186147 Bone Marrow Grafting for Leukemia and Lymphoma https://ClinicalTrials.gov/show/NCT00186147 Enrolling by invitation Stanford University 2069-12-31
NCT00159003 Analysis of Genetic Factors Related to Predisposition and Prognosis of Hematological Malignancies in Israel https://ClinicalTrials.gov/show/NCT00159003 Completed Hadassah Medical Organization 2017-07-01
NCT00005619 Analysis of Blood and Bone Marrow to Detect Residual Disease in Patients With Previously Treated Hairy Cell Leukemia https://ClinicalTrials.gov/show/NCT00005619 Completed Northwestern University 2001-08-31
NCT00085176 Neurobehavioral Complications in Children Who Were Previously Treated With Steroids and Intrathecal Therapy for Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT00085176 Completed Children’s Oncology Group 2009-09-30
NCT00002485 Development of Strategies to Increase Enrollment in Clinical Trials for Children With Cancer https://ClinicalTrials.gov/show/NCT00002485 Completed Children’s Oncology Group 2003-07-31
NCT00003790 Detection of Residual Disease in Children Receiving Therapy for Acute Myeloid Leukemia or Myelodysplastic Syndrome https://ClinicalTrials.gov/show/NCT00003790 Completed Children’s Oncology Group 2002-04-30
NCT00005881 Quality of Life in Children Treated for Cancer https://ClinicalTrials.gov/show/NCT00005881 Completed Children’s Oncology Group 2003-03-31
NCT00003931 Diagnostic Study of Gene Alterations in Patients With Acute Myeloid Leukemia https://ClinicalTrials.gov/show/NCT00003931 Completed Alliance for Clinical Trials in Oncology 2006-06-30
NCT00048958 Cytogenetic Studies in Acute Leukemia and Multiple Myeloma https://ClinicalTrials.gov/show/NCT00048958 Active, not recruiting Alliance for Clinical Trials in Oncology 2100-01-31
NCT00003861 Diagnostic Study of Patients With Acute Lymphoblastic Leukemia or Acute Promyelocytic Leukemia https://ClinicalTrials.gov/show/NCT00003861 Active, not recruiting Alliance for Clinical Trials in Oncology 2100-01-31
NCT00003793 Genetic Study of Children With Soft Tissue Sarcoma or Rhabdomyosarcoma https://ClinicalTrials.gov/show/NCT00003793 Completed Children’s Oncology Group 2005-12-31
NCT00003291 Molecular Genetic Lesions and Clinical Outcomes in Children With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT00003291 Completed Children’s Oncology Group 2006-03-31
NCT00042445 Brain Neoplasms, Leukemia and Petrochemical Exposures https://ClinicalTrials.gov/show/NCT00042445 Completed National Institute of Environmental Health Sciences (NIEHS) NA
NCT00015587 Molecular Epidemiology of Childhood Leukemia (Aka The California Childhood Leukemia Study) https://ClinicalTrials.gov/show/NCT00015587 Completed National Institute of Environmental Health Sciences (NIEHS) 2016-07-31

Registries

#If less then 500 registries

nct_id brief_title link overall_status source primary_completion_date
NCT04342117 Observational Trial of Real-World Treatment Utilization and Effectiveness of PI3K-inhibitors in CLL/SLL and FL https://ClinicalTrials.gov/show/NCT04342117 Recruiting Verastem, Inc. 2023-04-30
NCT03821727 SCT in Ph Positive Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT03821727 Completed University Hospital, Udine, Italy 2017-12-31
NCT03255668 Hematotoxicity in Maintenance Therapy of Children With Acute Lymphoblastic Leukemia https://ClinicalTrials.gov/show/NCT03255668 Completed Indonesia University 2018-10-15
NCT03197259 Chronic Lymphocytic Leukemia Registry Study - Multicenter Prospective National Study https://ClinicalTrials.gov/show/NCT03197259 Recruiting Izmir Hematologic Diseases and Cancer Research Help Association 2020-01-01
NCT03188874 Clinical AML Registry and Biomaterial Database of the Study Alliance Leukemia (SAL) https://ClinicalTrials.gov/show/NCT03188874 Recruiting Technische Universität Dresden 2025-09-30
NCT03023384 Feasibility Study of Intermediate Doses of ARA-C With Autologous SCT as Consolidation of Low/Intermediate-risk AML https://ClinicalTrials.gov/show/NCT03023384 Recruiting International Consortium on Acute Leukemias 2021-01-31
NCT02938858 French Registry of First-line Treatment of Acute Promyelocytic Leukemia https://ClinicalTrials.gov/show/NCT02938858 Recruiting Groupe Francophone des Myelodysplasies 2020-10-31
NCT02872987 GMALL Registry and Collection of Biomaterial: Prospective Data Collection Regarding Diagnosis, Treatment and Outcome of Adult Acute Lymphoblastic Leukemia (ALL) Patients and Related Diseases Associated With a Prospective Collection of Biomaterial https://ClinicalTrials.gov/show/NCT02872987 Recruiting Goethe University 2025-12-31
NCT02869529 Institut Paoli Calmettes Chronic Lymphatic Leukemia Database https://ClinicalTrials.gov/show/NCT02869529 Recruiting Institut Paoli-Calmettes 2030-01-31
NCT02869516 Institut Paoli Calmettes Acute Leukemia Database https://ClinicalTrials.gov/show/NCT02869516 Recruiting Institut Paoli-Calmettes 2030-01-31
NCT02863692 Registry of the German CLL Study Group https://ClinicalTrials.gov/show/NCT02863692 Recruiting German CLL Study Group 2020-12-31
NCT02760238 Myeloproliferative Neoplasms (MPNs) Patient Registry https://ClinicalTrials.gov/show/NCT02760238 Recruiting University Health Network, Toronto 2025-10-31
NCT02582879 informCLLâ„¢: A Disease Registry for Patients With Chronic Lymphocytic Leukemia https://ClinicalTrials.gov/show/NCT02582879 Active, not recruiting Pharmacyclics LLC. 2021-10-31
NCT02553304 Molecular Features Underlying Racial Differences in Survival of Taiwanese Chronic Lymphocytic Leukemia Patients https://ClinicalTrials.gov/show/NCT02553304 Active, not recruiting National Health Research Institutes, Taiwan 2019-01-25
NCT02192619 National Acute Promyelocytic Leukemia (APL) Observational Study NAPOLEON-Registry of the German AML Intergroup https://ClinicalTrials.gov/show/NCT02192619 Recruiting Gesellschaft fur Medizinische Innovation – Hamatologie und Onkologie mbH 2020-12-31
NCT01950286 Hyper-CVAD Treatment of Adult T-cell Acute Lymphoblastic Leukemia in Sweden. https://ClinicalTrials.gov/show/NCT01950286 Completed Region Örebro County 2013-02-28
NCT01890486 The Prospective Collection, Storage and Reporting of Data on Patients Undergoing Hematopoietic Stem Cell Transplantation Utilizing a Standard Preparative Regimen https://ClinicalTrials.gov/show/NCT01890486 Recruiting Wake Forest University Health Sciences 2023-05-31
NCT04182074 Monitoring the Diagnosis and Management of Acute Leukaemia In Pregnancy Study. https://ClinicalTrials.gov/show/NCT04182074 Recruiting University of Hull 2021-05-31
NCT04094051 Observational Study of CLL/SLL Treatment and Ibrutinib Treatment of CLL/SLL in Routine Clinical Practice https://ClinicalTrials.gov/show/NCT04094051 Recruiting The First Affiliated Hospital with Nanjing Medical University 2020-12-31
NCT04014764 Collect and Assess Tissue Samples From Subjects With Hematologic Malignancy https://ClinicalTrials.gov/show/NCT04014764 Recruiting Notable Labs 2022-09-30
NCT03881592 Real-World Data Study Focused on Chronic Lymphocytic Leukemia (CLL) Patient Treatment Options and Their Effectiveness https://ClinicalTrials.gov/show/NCT03881592 Recruiting Brno University Hospital 2019-06-30
NCT03760237 Cardiovascular Function in Acute Leukemia https://ClinicalTrials.gov/show/NCT03760237 Enrolling by invitation Abramson Cancer Center of the University of Pennsylvania 2021-12-31
NCT03662724 Venetoclax Registry https://ClinicalTrials.gov/show/NCT03662724 Active, not recruiting Hannover Medical School 2021-11-01
NCT03625583 The Hong Kong CML Registry https://ClinicalTrials.gov/show/NCT03625583 Recruiting The University of Hong Kong 2023-03-31
NCT03502876 Tolerance and Resistance to Ibrutinib in Patients With Chronic Lymphocytic Leukemia (CLL https://ClinicalTrials.gov/show/NCT03502876 Completed French Innovative Leukemia Organisation 2018-12-31
NCT00889798 Tumor Registry of Lymphatic Neoplasia https://ClinicalTrials.gov/show/NCT00889798 Completed iOMEDICO AG 2019-08-31